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CHAPTER I
INTRODUCTION
The pharmaoologioal properties ot the ohemiaally
homogenous group ot phenothiazine oompounds d1tter w1dely.
Phenothiazine (tig. 1), the parent compound possessing the basio
struoture of this group, had been synthesized in 1883 and had
been introduoed as an entihelmintio primarily in veterinary
medioine about 19)).
tive beaause

of

Its olinloal use in man has been restrio-

its hemolytic aotion.

fhe phenothiazines re-

oeived renewed interest as therapeutio agents within the past
two decades trom two separate researah groups.

In the United

states the searoh for more potent antimalarials during World War
II led to the synthesis ot various homologs ot phenothiazine
(1-).

fbe lO-dialkylaminoalkl1 phenothiaZine., the alosely

related homologa of chlorpromazine (OPZ). were first synthesized in

1944

by Gilman and ooworkers (1.2).

The pharmaoologiaal

properties of these compounds were not inve.tigated .inoe the ••
phenothiazine derivatives failed to satiary tbe antimalarial
interests of the.e researchers.

Independently. the seaond group.

headed by Halpern in Franoe, interested in the phenothiazines
as drugs exhIbiting potent ant1b1stam1n10 act1vity with lesser
~

slde ertects or toxioity than the known antlhistaminios, also
synthesized 80me lO-dialkylaminoalkyl phenothiazines
1

(4.5).
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Figure 1

Structural Formulae of Phenothiazine,
Promethazine and Chlorpromazine

Phenothiazine

cx:X)

I
",CH
CH 2 -?H-N'CH:
CH 3

Promethazine
(Phenergan)

Chlorpromazine
(Thorazine, Largactil, etc., see text)

)

The.e derivatives, tor example, promethazine (phenargan, tig. 1)
were round superior to the other known antihistaminic drugs.
During the olinioal trials of the antlhistaminl0
phenothiazine derivative., tor example, promethazine, marked
hypnotio aftects were noted.

Halpern et al. (6) reporting on

the 100al anesthetio action of various antihistamine drugs observed that oertain of the phenothiazine derivatives exhibited
a distinotive type ot oentral aotion.

Winter also reoognized a

·oentral" oomponent ot aotion ot a pkenothlazlne oompound. promethaZine, trom his study ot drugs causing tha potentiation of
hexobarbital sleeping time in mioe (1) and the depression ot
the oonditioned retlex in rat. (8).
A ahemioal oongener of promethazine which would exhibit
more potent oentral a.ction was sought.

It was during this searoh

that the syntheSis of lO-()-dimeth1laminopropyl)-2-ohlorophenothiazine (R.P. 4560) was aooomplished in 19,0 at Rhone·Pouleno
Speoia Researoh taboratorien and reported by. Charpentier et al.
(9) in 19$2. The generio name of ohlorpromazine (CPZ) was
~

proposed by the Frenoh group (9).

Prior to the publioation ot

the synthesis ot CPZ by Charpentier studies ot the'pharmaoologioal properties had been in progress (10) and reports ot
c11nical trials of R.P. 4$60 had b.en published (11-16).

The

drug had been introduoed (11) by various trade names 1n different
countries, tor example, Thorazine (United states), Largaotil
(France, England, and Canada), Megaphen (Germany), Hibernal

4
(Sweden), A.pliotil (Brazil), AMiniazine (Russia), and
Ampllaotil (Argentina).
Courvoisier et ale (10) reported in detail on the
pharmaoodynamic properties of R.P. 4560 (GPZ), a new compound
utilizable to potentiate anestheslaand artifioial hibernation.
Promethazine and CPZ were used in Europe a8 components for the
"oooktail lytiqu.", a mixture used for the produotion of artificial h1bernation during surgery.

This mixture usually consisted

of an analgesio, a parasyapatholytic, an antihistaminic, and a
hypothermio agent, and was administered as a pre-anesthetio
preparation.

Promethazine and OPZ were used in the preparation

to produce the latter two eftects.
ates demonstrated

~hat

Courvols1er and her

assool~

CPZ enhanoed the aotion ot general

anesthetics, analgesios, and narcotic drugs, and exhibited
sympatholytic, spasmolytic, hypotenslve, hypothermic, sedative,
hypnotio, antioonvulsant, anti-emetio, antItlbr1l1atory and
analeptio aotivities.

Tne drug was oapable of exerting a de.

pressive aotion on the oonditioned reflex aotivity and of auppressing the psyohomotor activity ot the alcoholio, it reduoed
oapillary permeability, exerted soa. proteotive aotion against
hemorrhagio and traumatic shook} and it prevented blood ooagulation. but at a oonoentration not attained in therapy;

OPZ was

found to be praotioally devo1dof antihistaminic aotivity.
.v~r,

CPZ was introduoed into medioine as an antiemetia and

preanesthetic agent.

How-
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In addition to the introduction of CPZ as a useful
potent anti-emetio agent (18,19) capable of blocking the aotion
or apomorphine on the ohemoreoeptive emetio trigger zone (20-22),
and as an agent useful in the potentiation of anesthetios (15,

23, 24) analgesios (25,26), and hypnotios (15), early olinioal
reports (13, 16, 27, 28) made it evident that CPZ exerted a nonhypnotio'depressant aotion on the oentral nervous system.
Animals given OPZ displayed a oalming or dooilizing errect; they
beoame lethargio and motionless (10).

Thus, the usefulness 01'

CPZ in alleviating anxiety, agitation and hyperaotive motor
states in psyohotic and psyohoneurotic individuals beoame apparent.

Patients suttering trom simple or neurotio depressions and

oertain melanoholias responded well to CPZ treatment (28).
anxiety and tension 01' neurotios were reduoed (21-30).

The

Agitated

behavior was oalmed without the produotion ot naroosis.

~.

observed oalmness experienced diffe:red troll that following the
use 01' sedatives.

The somnolent patient could readily be

aroused without exhibiting the stuporous state usually displayed
by sedatives.

A new term was in'i;roduo6.ito desoribe the pharma-

oologioal aotion 01' OPZ --Htranquilization", and the era 01'
tranquilizers was introduoed with the advent of OPZ.

!be

introduotion of OPZ as a useful agent in this field of medioine
has done muoh to revolutionize conoepts of mental health.

The

usefulness of CPZ as an anti-emetia and preanesthetic agent was
overshadowed by its greater usefulne.s in psyohiatry.

6

The effeotiveness of CPZ in it. applioation 1n psyohiatry was reviewed by Viaud (31) in 1954, leas than two years
followIng the report of the synthesis of this compound.

Sinoe

that ti•• the literature pertaining to the applioation of CPZ
in mental health and psyohiatrio treatment grew oontinually and
Is, at present, voluminous.

The Crug has found

~pplio~tion

in

the treatment of severe agitation, aoute and ohronic sohiaophrenia, manic states, depression, where anxiety and agitation predominate, psyohoneuroses and psychosomatio disorders, addiotion
to alooholio and narootio drugs, and delusional, belligerant and
anxiety reaotions in organio mental disorders (32).

OPZ has been

used suooessfully as an antiemetio and a pre-anesthetio agent.
Several review artioles pertaining to the pharmaoologioal and tranquilizing actions of CPZ are available (33-38).

A

rather thorough comprehensive review, oontaining 6800 referenoes,
on the ohemistry and pharmaoology ot CPZ and related phenothia.zine tranquiliaers was presented reoently by Soilenker and Herbat

()8).

Killam and Killam ()4,35) oite the ava1lable ev1dence

indioating the involvement ot tha retioular system as a site for

OPZ action.

Domino (33) reviewed the data on

ot CPZ action.

th~

mode and sites

Involvement of the hypothalamus and limbic system

in the aotion of OPZ has also been indioated.

Considering the

multifaoet pharmaoological responses produoed by CPZ administration, it a.ppears that the meohanism ot aotion of CPZ may be
oomplex.

7
Tissue distribution of CPZ following ita administration
in vivo has been reported for dogs (39;40), mioe (41), rabbits
(40), rats <40,42), and monkeys (42).

However, there a;J,ears to

be a laok of agreement among these investigators as to the distribution of CPZ within the tissues, particularly as to its
localization within the brain.

WeohslGr and Roisin (42) stated

that after the administration ot massive doses (100 miorogm. per
gm.) of CPZ, only traces of this oompound could be found in the
brain.

Low oonoentrations ot 835 CPZ in brain were also reported

by Fyodorov (40), whereas Salzman and Brodie (39) reported that
CPZ aocumulates in the brain.

Their findings essentially agreed

with those of Christensen and Wase (41).

other differences exist

between that data obtained by Salzman and Brodie and those
obtained by Yasuda and Aoki (43).
Methods have appeared in the literature pertaining to
the chemical analysis ot CPZ trom biological fluids
trom tissues ()9,48).

(44-47) and

The prooedures describing the quantitative

determination ot CPZ in biological tissues present oertain disadvantages.

Salzman and Brodie's procedure ()9), based on an

extraotion ot CPZ from an alkalinized biologioal solution into an
isoamyl aloohol-heptane mixture, and subsequent re-extraction
into dilute hydroohloric aoid, requires an ultraviolet speotrophotometer tor the determination of CPZ.

Thus, a correction for

tissue blanks is neoessary because the blanks read high in the
ultraviolet light.

Moreover, they report that by their method,

8
only

40%

ot OPZ was reoovered after the addition ot the drug to

brain homogenate.

Weohsler and Forrest (48) modified the

Salzman and Brodie method; they ohanged the oomposition of the
organic extraotion mixture. substituted glacial aoetio acid tor
the hydroohlorio aoid. and added hydrogen peroxide.

95%

OPZ recoveries trom brain tissue.

They olaimed

However, utilizing the

modified prooedure, Wechsler and Roizin (42) reported very low
oonoentrations ot OPZ in the brains of monkeys and rats following
massive doses of the drug.

The data of Weohsler and Roizin

suggest that their reo overy of CPZ trom tissues. in vivo, was
incomplete.

CHAPTER II
PtffiPOSES AND APPROACHES TO THE PROBLEM
The methods available for CPZ analysis from biologioal
tissues appear inadequate, primarily beoause of insuffioient
reoovery and of the neoessity of oorreotions for the high tissue
blanks.

One of the purposes of the researoh desoribed here is

to present a ohemioal prooedure whioh oan eliminate these inoonvenienoes.
The ohemioal prooedure based upon the oxidation of CPZ
with sulfurio acid, previously desoribed by Duboat and Pascal

(44)

for the determination of OPZ in biological fluids, oonsti-

tuted the basis for the present method.

However, the oxidation

was performed in the presence of ferrio ion.

~lis

prooedure

provided the advantages of obtaining speotrophotometrio readings
in the visible range and eliminating the necessity of oorreoting
for tissue blanks and for inadequate reooveries..

The average

reoovery of CPZ added to brain homogenates was about 90%.
Drugs are usually distributed throughout the body onoe
they are administered into the system.

Certain tissues oan

exhibit definite affinities for that oompound and can accumulate
the drug either in high or signifioant oonoentrations.

Informa-

tion about the distribution at a particular drug may provide
some inSight pertaining to the site of aotion for that drug.
Often the localization of the drug in an organ or tissue may be
Q
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assooiated with the ooncept of the target site of action, that
Is, the organ oharaoterized by high oonoentrations ot drug Is,
at the same time, responsible for the pharmaoological etreot.
Th. accumulation of iodine in the thyroid gland tor the treatment of goiter (49) may be oited as an example.

Conoentration

of a drug in a particular tissue is not always a necessary criterion for the site or drug action.

A drug may oonoentrate in

large amounts in some organs or tissues and produoe no
tic or pharmaoological activity.

~he

the~apeu

deposition of high ooncen-

trations of thiopental in the rat, is marked even after the
animal haa recovered from the hypnotio .treot of the drug (50-52),
It becomea apparent then that the fat serves as storage sites
rather than the site ot aotion.
1s

dil~aotly

Dig1talis, a drug whoae eftect

on the I'IJ.yocardiulJ3, also does not seleotively

looal1ze in heart musole (49).
Pharmaoologic eftect of a drug may often be related to
its conoentration in plasma (52-54) as ,iell as to its deposition
or aCCUMulation in the tissues.

That o?th these faotors playa

role 1n drug action would be little disputed.

Brodie et al.

(SO,51) interpreted the deposition of thiopental into body fat
8S

being related to the termination of its anesthetio aotivity.

Almost a deoade later, Goldstein and Aronow (S2) extended the
earlier experiments and showed that the

terMin~tion

aotlvity could be more oorreotly assooiated with
conoentration presented in the

8,l""eas

8.

of thi0pental
oritiaa,l

of the brain affeoted.
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In this oonsideration, the question arises whether
the drug aotion is assooiated with the target organ or with a
reoeptor site or sites on that particular organ.
drug

~ay

be seleotive in its action.

That is, a

It may affeot a speoific

tissue or a speoifio site on that tissue, perhaps a sinp,le oell
O~

group ot oells which are highly specialized or sensitive to

that partioular drug.

These may be considered as reoeptor oells.

Furtherll1ore, the sensi ti vity of that reoeptor oel1 or group ot
oells to the drug may be limited to a small area looated on the
surtace or the interior ot the oell, that is"same specitio site

ot the cell.

Sinoe

~.J.

Clark tocused attention upon the impor-

tance of the molecular organization of the cell, present conoepts
imply that moleoules of compounds, or drugs, do not reaot with
the oell as a whole, but with other molecule. of whioh the cell
may be composed or whioh it oontains.

These cellular moleoular

aomponents become ot importanoe onoe the site of aotion tor that
particular drug is determined.
Distribution stUdies often help provide some indioatien
of the drug aotivity.

It not trom the aspeot ot site ot aotion,

these stUdies may provide the necessary information of absorption,
storage, metabolism, exoretion patterns, toxioit7, usefulness in
therapy. and perhaps dosage requirements 1n relation to effeots.
Sinoe the reports ot tissue distribution ot OPZ
following its adm1nistration to animals appear inoonolusive, it
was of interest to study tissue distribution ot OPZ in oats.

In
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view ot the pauc1ty ot data on the fate ot CPZ in animal tissues,
its distribution was traced for forty-e1ght hours atter its
adm1nistr~tion.

Ce~tain

behavioral and pharmaoologic observations

were correlated with tissue levels of CPZ.
From the

observ8~~1ons

obtained in vivo, it was consid-

ered interesting to study whether significant uptake ot CPZ by
the tissue can occur in vitro.

Many methods

(54-56)

are avail-

able for studying protein interaction with relatively small ions.
such as drugs.

Goldstein (54) classified the teohniques employed<

in vitro under three basio prinoiples:

1) Thoae prooesses whioh

study protein interactions based upon the reduotion of the
thermodynamio aotivity of the drug whereby the conoentration and
the biologioal aotion of the drug may be reduoe4; 2} Those proo-"
esse. whioh measure alteration of drug propertie., for example.
solubility. diffusion. stabilization.

Reduction of thePmod,namio

aotivity may also explain some of these effeats, and 3) Tho ••
processes whioh ()bserve changes in the properties and behav10r
of the protein.
The first two principles, thus, deal with teohnique.
which involve changes in the interaoting moleoule, that is, the
drug.
r.sult~

Equilibrium dialysis, an sxample of the first group,
in a reduotion in thermodynamic activity ot the smaller

moleC'ule.

Osborne (57). almost s'\.xty years ago, demonstrated

the usefulness of this teohniQue for protein interaot'ons with
salts.

The applioation of the equilibrium dialysis teohnique to
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the study of organio ions was made by Klotz, Walker, and Pivan

(58) who reported on the binding ot sulfonate anions ot methyl
orange and azosulfathlazole by bovine serum albumin.

Sinoa then,

many slgnificant equilibrium dialysis studies with organio oompounds ha.ve been reported (54,59-64).

Most of the investigations

utilizing thia technique have. been on purif1e. proteins, tor
example, bovine serum a.lbum.ln and globulin.
The equl11blium dialysis teohnique in the following
experiments was performed with OPZ dialyzed alainst the tissue
homogenate.

!he primary purpose of the study utilizing tn.

equilibrium dialysis prooedures was to determine whether interaotion ot CPZ with tissue homogenate. can ooour and whether yarious tissues in this system would exhibit difterenoes in uptake
of CPZ somewhat similar to that observed in vivo.
tion by the tissues for the
gated.

upt~e

Thus oompeti-

of CPZ in vitro was investi-

Some preliminary experiments pertaining to the strength,

or affinity, of the tissue binding of OPZ were made.
Inte~aations

ot small moleaule., for

e~ample.

druga,

with maoromoleoules, the oellular constituents, are ot interest
in pharmacology from the standpoint ot drug aotion, storage,
metaboliuM, exoretion, and transport.

Of the man7 available

methods tor studying smdll ion interaotion with proteins, in
vitro, the equilibrium dialysis teohnique vas .eleoted because it
is felt that the results obtained by this teohnique may be used
to provide some information for the .eohartism of CPZ aotioQ.
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These results

a,. be oonsidered prel.iminary work toward the oon-

sideratlons ot CPZ aotion at the moleoular and possibly the
"reoeptor" level.

Investigations ot the oharacterIzation of the

oellular oomponent or oomponents involved in the interaotion with
CPZ were not pursued in the present work.
Pro. the applioation of the law of mass aotion to the
multiple equilIbria involved in lan-protein

Inte~aotion8,

results

obtained trom the equilIbrium dialysis teohnique emplOying purlfied proteins oan be extended for the oalculation ot the energy
ot assooiation ot eaoh suooessive ion to a protein as well as to
the number ot sites available for the binding ot the ion ($$).
While this applioation Is beyond

~he

soope of the present exper1-

.ents, 1t would inde.d be ot interest tor a future investigation.

CHAPTER III
MATERIALS AND METHODS
Prinoiple

~ ~

ChlorEromazine Method

The ohemiaal prooedure based upon the oxidation of CPZ
with sulfurio aoid, previously desoribed by Dubost and Pasoal

(44)

for the determination ot CPZ in biologioal fluids, oonsti-

tuted the basis for the present method.

However, the oxidation

was performed in the presenoe of terrio ion.

This prooedure

provided the advantage ot obtaining results trom speotrophotometrio readings in the visible range.
CPZ was extraoted by diethyl ether ira. alkalinized
solutions ot tissue homogenates or ot Whole blood.

The drug was

then extraoted trom the ether into 2M sulfurio aoid.

An aliquot

of this aqueous layer. to whioh ferrio ion had been added was
mixed with an equal volume of oonoentrated sulturio aoid to produoe a oherry-red oolor whioh showed an absorption maximum
between $20 and S30
meter.

275

m~(Fig.

2) in the Beckman B speotrophoto-

Maximum absorption in the ultraviolet range at about

.~ia

shown in figure ).
The intensity of color read at 5)0

m~depend.d

oonoentration of sulfurio aoid and of terrio ion.

Figure

upon the

4

denotes the relation between sulfurio acid oonoentration and
color development at two Qonoentrations of CPZ.

In the absence

of terric ion, little oolor was produoed even at 30 m1orogm./ml
1
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Figure 2:

Upper Half.

ohlorpromazine.

Absorption speotrum in visible range for

Absoissa,

optical density (O.D.).

wavelength (A)

in~.

Ordinate:

Beokman B speotrophotometer was employed

Chlorpromazine oonoentration, 20 miorogm. per ml.
Figure 3:

Lower Half.

tor ohlorpromazine.

Absoissa:

optioal density (O.D.).
ployed.

Absorption speotrum in ultraviolet range
wavelength ().)

in~.

Ordinate:

Beokman DU speotrophotometer was em-

Chlorproma?ine oonoentration, 10 miorogm./ml.
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O. D.
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Figure

4:

Effeot ot sulfurio aoid concentration upon color re-

aotion of chlorpromazine in presenoe and in absenoe of ferric
ion.

Solid lines represent oolor development in presence of

ferrio ion, broken lines refer to oolor development in abseno.
of ferrio ion.

Circles and triangles denote 20 and 30 miorogm.

per ml., respeotively, of ohlorpromazine.
tinal sulfurio a01d oonoentration.
at $)0

~.

Absoissa:

Ordinate:

molarity of

optioal density

20

ot CPZ in the tinal reaotion mixture, and the difterenoe in optioal density between 20 and 30 miorogm./ml ot CPZ vas insuffioient
to lend itself for an analytioal prooedure.

In the presenoe ot

terrio amD&onium sulfate (200 miorogm./ml), intense oolor was
produoed by stronger (trom

4

to 9 M) oonoentrations of sulfurio

aoid; oolor intensity seemed to approaoh a pl1teau with 8-9 M
oonoentrations of sulfurio aoid.

Figure

4

also shows the de-

pendenoe of the oolor upon terric ion in the presenoe of sulfurio
aoid.
Pigure

5

shows the erteot on oolor development when

ferrio ion oonoentration was varied and the oonoentration ot
vas 20 miorogm./ml in the final reaotion mixture.

CPZ

In the absenoe

of sulturio a01d, the oolor was slight even when oonoentrations

ot terrio ammonium sulfate were aa great as 1000 miorogm./ml.
Furthermore, the color was unstable, and it faded to a turbid
orange within ten minutes.
(Fig.

5)

The presenoe of sulfuric aoid

both intensified and stabilized the oolor.
Thus terrio ion alone, or sulfurio acid in the absen.e

ot ferrio ion, were not satisfaotory for quantitative analysis or
CPZ.

For conoentrations ot ferric ion and sulfurio aold emplo'1ed

In the prooedure, the relationship between CPZ ooncentration and
optical densit'1 followed Beer-Lambert'. Law over the oonoentration range of from 1 to

35

miorogm./ml of OPZ (Fig. 6~.

Oxidation to the red ohromophore did not ooour with
the ouprio, mercurio. zino, molybdate, cobaltio, manganio, or

I
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5:

.42
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1.04
.83
mM Fe+++

Oxidation of chlorpromazine

presence of sulfuric acid.

by

1.24

1.45

ferric ion in the

The two curves refer to oolor davel-

opment with inoreasing oonoentrations ot ferric ion in
9 M H2S04.

Each point represents:

readings, 1n the case of

4.5

1.66

4.5

and

one experiment. duplicate

M H2S04; two experiments with dupli-

oate readings in ,the oase ot 9 M H2S04 (vertical bars represent
range of optioal densities).
optical density at 530

~.

Absc1ssa.

mM Pet++.

Ordinate:

I
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Oxida.tion of ohlorpromazine to a oherry-oolor ohromo-

phore in the presenoe of sulfurio acid and ferrio ion.
oonoentration of chlorpromazine, miorogm. per rol.
optioal density at 530 trlft-e

Absoissa:

Ordinate:

From two to four experiments per

ohlorpromazine oonoentration indioated; eaoh experimental point
represents duplioate readings.
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ohromio ions, nor did it occur when the ferrio ion was oomplexed
as in ferrloyanid. or ferrooyanide.

The oeric ion, however, was

found as effeotive as the ferric 10n (65).
Detez:mina tion

2! .Q!.! .!n

Blood

.!!!.<! ....O...t.;.;;h....e ...!" Tissues

Homogenate. of brain, liver, muscle and other tissues
were prepared in a ratio of 1.0 gm of tissue to 2.0 ml water.
Whole blood, 01"1.0 ml of whole blood diluted with water to 3.0
ml, was used.

To 3 ml of the homogenate or of the blood sample,

20 ml of anhydrous diethyl ether was added, tollowed by 2 ml at

.$ N sodium hydroxide.

The mixture, in a tightly stoppered bottle

was shaken meohanioally tor thirty minutes.

The aqueous layer

was disoarded and the ether layer was washed onoe with
water.

S.O

ml ot

CPZ was then extraoted from the ether by shaking for

sixty seoonds with three separate portions of 3.0 ml of 2 N
sulfurio anid.

<4

M)

The traoes of ether trapped in sulfurio aold

were removed overnight in an air oven at 50-55

0

C.

Subsequently,

0.2 ml of 2 per oent (0.0415 M) ferrio ammonium Bultate was

added, the volume adjusted to 10 ml with 0.1 N (0.2 M) sulfurio
aoid, and a 5.0 ml aliquot of this solution was mixed with an
equal volume of oonoentrated sulfurio a01d oooled in an ice bath.
After reooo11ng, the mixture was permitted to equilibrate for
thirty minute. in the dark at room temperature and then read at

530

~

in the Beokman Model B Speotrophotometer.

A blank, oon-

sisting of 3.0 ml of distilled water, as well as standard aolutioDa oontainin

or 200

m1oro~m.

of
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were carried through the entire procedure.
Methods Employed

~

Animal Procedures

Fresh aqueous 2 per oent solutions ot OPZ hydroohloride
were employed for the intravenous injeotion tnto the saphenous
or temoral vein of adult cats.

The doses were

40 miorogm. per

gm. (30 oats) and 20 miorogm. per gm. (2 cats).
Rapid intravenous injeotion ot 40 miorogm. per gm. ot
CPZ is usually tatal within two minutes.

Slow and rapid adminis-

tration was, therefore, employed to determine tissue levels of
CPZ after prolonged time intervals and immediately after its administration, respectively.

In the former oase, injeotion inter-

vals ot five to fifteen minutes were used.

Tissue levels' of OPZ

were determined at intervals timed from the start of the injeotion until the animal was saorifioed by intravenous injeotion of
air (27 cats).
possible.

Tissue samples were then removed as rapidly as

Blood levels of CPZ were determined immediately, other

tissues were frozen on dry ioe, and stored until analyzed.
To ·determine CPZ oonoentrations in whole blood and in
other tissues immediately following its administration, polyethylene cannulae were inserted at least one week before CPZ injeotion.

Cannulae, inserted while the animals were under ether

anesthesia. were plaoed into the right femoral vein for rapid
(15 seoond) injeotion of CPZ and into the left femoral artery for

rapid withdrawals of blood (3 cats).
oolleoted 1n he arinized s

in~es.

All blood samples were

2S
Reotal temperature, reaction to pain, righting reflex,
pupillary diameter, and the nictitating membrane were observed
in seventeen animals.

In the oourse of preliminary experiments

on the hypothermic aotion of OPZ, it was notioed that immobilization resulted in a fall in body temperature even in unmedioated
animals.

'ro distinguish between the hypothermic B.otions oaused

by the drug and by immobilization, the following prooedure was
employed:
two to

tive oats were restrained in a supine position for

twenty~rour

hours, and their reota1 temperatures measured.

After permitting at least tour days tor reoovery, CPZ was administered (40 miorogm. per gm., Intravenously), the oats were restrained again for various time intervals, and reotal temperatures were reoorded hourly for forty-eight hours.

Analgesia was

measured by observing the reaotion of the oat to pain produoed by
applying a hemostat clamp on the tailor the toe pad for fifteen
seoonds.
Prinoinle of Equilibrium Dialysis
In essenoe, in the equilibrium dielysis technique, two
oompartments are established by the presenoe of a membrane, permeable to smaller ions but impermeable to larger molecules such
as proteins and various struotural oell components.

Tissue

homogenates, prepared in a suitable burfer, oonstituted the inner
oompartment; known conoentrations or CPZ in the same butfer were
in the outer compartment.
dure are described bel w

Several varIants of this basic proce-
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whioh the penetration of CPZ through the membrane may OOQur,
aliquots were analyzed for CPZ content.

Interaction of CPZ with

oellular oomponents ot the tissue homogenate may be oonsidered
to have ooourred 1t. at equilibrium, the amount of CPZ per unit
volume lound in the inner ohamber was greater than the ooncentration of CPZ in the outer chamber.

However, if OPZ ooncentrAtions

in both chambers, at equilibrium, were approximately equal. it

mar

be assunu'td that interaotion of OPZ wi th oellular oomponents

was negligible.
Two inherent souroes of errox- in the equilibrium dialys18 method have been reoognized

(55).

For one, there ma,. be

asymmetry in the distribution ot the small molecule. if tt is
ionio, as a oonsequenoe ot th. Donnan membrane ertect.

Either

oorreotions can be employed to lninim1ze any disorepanoies in

distribution due to the Donnan effect, or it oan be reduoed to
negligible proportions by the addition of an innoouous eleotrolyte (66).

The assymmetrio distribution of the small ions

to the Donnan efflBot may also be eliatnated if the
at the isoel.atria point.

p~

dUIB

selected i.

In the present experiments, the phos-

phate bufte%' was aonsidered as provid.ing an inno(}uouS eleotrolyte.

Seoondly, absorption ot the small molecule (CPZ) to the

membrane may oocur.

Correotion or possibly

souroe ot error oan be made by employing

II.

el~"minAtion

of this

oontrol dialysis, In

whioh the butter solution replaced the homogenate in the inner
chamber and CPZ 1s measured in both oompartments.

This prooedure
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was adapted in these. experiments.
For meaningful

.q~ilibrium

d1a17sis results, the vol-

ume. of the two cbambers should remain oonstant.

Osmotio pres-

sure ettects may arteat the experimental results obtained

tr~

equilibrium dialysis by oausing shitts in the volume of water
between the two oompartments.

Low conoentrations of homogenate

or of the test drug tend to minimize or eliminate osmotlo pressure eftects.

'fo asoertain that osmotlopressure etreots did not

enter as a variable during these experiments, volume measurement.
or the Inner oompartment were performed periodioally.

No signi-

fioant ohanges In volume of the Inner oompartments were observed
with the oonoentrations of homogenate or of drug employed.
So~utions

EmPloyed

~

Equilibrium Dialysi.

CPZ Stook Solut10ns
--------------stock solut1ons

of 500 mg. CPZ hydroohloride per 50 ml

water were prepared and kept refrigerated in the dark unt11 u.ed.
Aliquots were removed and 411uted with phosphate bufter on the
da7 ot use.
Thimerosal solution
A oommeroial preparation ot tht'uerosal (Eli Lilly and

00.), 1:1000 solution, was employed.
was diluted to 10 ml with water.

0.5

1 ml ot the stook solution
ml of the thimerosal dilu-

tion was added to eaoh 30 ml ot butfered CPZ solution.
Phosphate Buffer Solutions
Fisher
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soientifio, A.R. (Lot #120607), F.W. 141.965 was used.

9.48 gms.

per liter of water was prepared as stook solutions.
Potassium dihydrogen phosphate, KH2P04' Fiaher scientIfic, A.R. (Lot 1722191). P.W. 1)6.091 was used.

9.08

sma.

per

liter ot water was prepared as stock solutions.
Des1gnated proportions of' each were mixed to prepare th
phosphate bufter employed in the experiments (s •• appendix).
Preparation

~ ~i •• u.

HONOaenate.

The initial experiments were performed with the inner
ohambers oontaining homogenate. prepared in a ratio ot 1.0 gm. ot
tissue to 2.0 ml of phosphate bufter (that is, 1:3 tissue hoaogenate. similar to that desoribed in the previous section for the
anal'1.1s of tissue distribution of CP.Z in vivo).

The 1: 3 homo-

genate dilution had b•• n •• leoted for the analysis ot tissues obtained trom the oat which had been administered OPZ beoause ot
oonvenienoe of volumes sinoe at instances CPZ might be present in
oonoentrations insuffioient to be analyzod from less than 1 gm.

ot tissue.

This homogenate preparation, 1:3, was undesirable tor

the dialysis procedure because the tissue was too conoentrated.
Further~ra,

or

the 1:3 homogenate preparation exhibited an uptake

CPZ during equilibrium dia.lysis Hhioh required high dilutions

for the analysis of CPZ.

The level of CPZ in the inner oompar·t.

ment when homogenates of 1:10 or 1:100 tissue dilution were
employed was at a suffioient oonoentration for oonvenient analysi8
her.tore
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utI1Izlng the tissue homogenates prepared as 1110 dl1u_ions (1
gDh

ot tissue plus 9.0 ml solution) or 1:100 dilutions in thf)

phosphate butter used for that partioular experiment.

Tbe prep-

aration of the latter dilution vas efreoted by diluting aliquots
of the 1:10 tissue homogenate to the appropriate volume with the
phosphate burfer.
Boiled Homogenate
Tissue homogenate (1:100) prepared as desoribed 9bove
was plaoed on a hot water bath at 90

0

C for two hours.

The tubes

were covered with glass oondensation bulbs during this proaedure.
After oooling to room temperature, suitable aliquots were pipetted into the dialysis bag.
AGed Tissu!

Homog~nate

Aged tissue refe.!'s to ti-ssue homogenate (1:100) whioh

had been prepared as described

0-4 0 C for

tainers at

Preparation

~ ~

~bove,

stored. in stoppered con-

a period of two to four weeks.

Dialysi. Tubina

Por equilibrium dialysis, the membrane should be permeao16 to water and the drug under inVestigation, and impermeable
to the binding substance suab as, the protein, or, in this

in~

stan•• , the non-diffusible aonstituents of the tissue bomogenate.
Cellophane dialysis tubing appeared to be suitable.

vas a

s.~1.8e

vi8008e

The tubing

produot prepared trom regenerated aellulose by a

process.

Beside oellulo •• , the manufaoturer atat •• that

,30

the tubing "7 oontain

gl7oe~1ne,

wate. and traoe. ot sulfur
App~eQtl7

oompounds (approximatel, 0.1 per oent).

quantity ot sulfur left 1"1'oDl the manufaoture

or

the

this small
can

IUl~~in8

interfere during binding studies of various metallio ions.

In-

terterenoe in studies of protein oomplexes of some metals by the
sulfur lett in the oasings has been reported
r.soval 01' sul1"ur prior to the use ot the

(55).

tub1n<~

Therefore the

i8 indioated.

!he method suggested by Hughes and Klotz

(55) tor

the

preparation of tubing for equilibrium dialysIs oonstituted uhe
basic prooedure used in these

e~p.rlments.

Lengths of aouut ten

inoh•• ot the oellophane cas ins were immersed in a beaker o'dIstilled water, and. heated 1n a boiling water bs.th at 86 0 C for
~5-60

minutesJ thE) strips were transterred to fresh d1.stI11ed

water and the heating ",8r1od was repented.

The strips were then

transterred through several washings of distIlled water
temperature and kept 1n distilled

wat~r

&~

room

until ready tor use.

A

sutfioient number of strips were removed trom the distilled water
and soaked overnight in the appropriate phosphate burter used tor
the equilIbrium dialysis prooedure.
Excess buffer was removed by pulling the strip between
the .fingers three or tour times.

A double knot was tied on one

end and the tissue homogenate in the appropriate butter, or, when
used tor controls, the butter solution alone was plpetted into
the dialysis bag.

The top was then t1ed Into a double knot, and

the tips ot the bag were out close to the knots at both ends.

A

)1

'ht-• .,d, peraa1'tlng tor ,,.••40. ot aot108 of the

baa,

was t184 '0

one end 1n ord.r to facilitate easy removal ot tn. 41al,sl. bas

fro. the te.t tube.
D1all818 Proc.dure
Th1rty ml a.liquots of the phospha',e buffered CPZ solution were pipettod into

40

ml polyethylene tubes.

~~1mero8al

(0.5 m1 ot 1:10,000 solution) was added to elim1nate baaterial
A dialysis bag oontain-

growth during the experimental interval.

illg 10 ml ot the tissue homogenate prepared as desoribed above

wal immersed into the CPZ solution.

Paratilm layered beneath the

rubber stopper was used to tightly stopper the tube.

The inner

coapartmont ot the aontrol assemblies oontained 10 ml ot butfer
solution but no homogenate.
analyzed for CPZ.

Aliquots of both o,)mpartm.euts we,.,..

control dialysis assemblies were preparQQ to

assure that sufficient time to attain equilibrium elapsed aDd to
pro'9ide a oheck against errors due
oellulose dialysis tubing.

tf)

absorption of GPZ onto the

EquIlibrium. was determined by emplp7-

ing a sarles of similar chambers trom which at varying intervals
samples were rem.oved for analys1s of OPZ.

ascertained when the conoentration of
DO

CP~

Thus, .qui11brlwa was
of the oham.bers ihowed

further ohanges or for oontrol, CPZ conoentration in one lnner

and outer chamber were approximately equal.
Aooording to Hughes anei Klotz

(5»

adequate stirring

should be maintained to hasten the equilibrIum time.

M1xlt!g

)2

method, a ugnetic stlrring bar was plaoe" In the outer .ompa.r1ll'Iu9nt,t:loD.eq,uently, the ti •• ue homogenate .ettled during the
dialyai. prooedure.

The question was rais.d that the settling

of the homogenate may reduoe the surfaoe area of the tl •• ue oomponents exposed to the CPZ moleoule.

In the other teohnique

theretoN, the Whole assembly was plaoed onto the Eberbaoh shaking maohine.

oas..

No se1ltling ot homogenate ooourred in this latter

Both mixing prooedure. were performed

so

tha.t the tube.

were enolosed in a darkened container in order to reduGe the production of oxIdation produGts formed by OPZ trom exposure to
light.
At the <ie.ignated intervals whioh oonstltuted the oonolu.lon of the experiment for that partioular a •• embly, the dialys1a bag was removed and blotted dry with tis.ue paper.

One

end 01' the bag was out just below the knot: and the content. poured
into a te.t tube.

In the situations where settling of the homo-

senate ooourred, the bag was inverted several time. to assure
adequate resuspenslon 01' tbe bomogenet. prior to removing the
aliquot for analysis of CPZ.
At the termination ot the experiment the pH or th.
butter, the buttered CPZ solutions, and the solutions ot the
outer compartment ot eaoh re.actlon mlxture were read on a Beckman
ZeroDlatic pH Instrument.

Changes in pH were not ob ••rved 1n

reaotlon vessel even forty-elght hours atter the start ot the
experiment.

anr

))
Three approaahe. of the equilibrium dialysis pro ••dura
were designed to atudy the uptake, afflnlt1. and ao.petition
between the tisau •••
1) For the meaaurement of uptake of CPZ, the prooedur.
as desoribed above wal employed, that ls, OPZ in the outer solution was dialyzed against the tissue

homog~nate.

2) Similar experiments were performed using a single
outer ohamber and two or more tissuea in separate dialysis bags
to show whether oompetition for CPZ Hould oocur bet,>1een tissues.
In these latter experimenta, the ratio of total homogenate volumea in the inner oompartments

1;0

that of th e buftered CPZ volume

in the ater oompartment was identioal with the ratio whioh obtained in the measurement of uptake.

For example, when four

homogenates ot oerebrum, heart, liver, and lung, were used to
obaerve whether oompetition would oocur between theae tlssue.,

8.0 ml of eaoh homogenate in separate d1alysis bags were suspended 1n 96 ml ot buttered CPZ solution, or 2.5 m1 homogenate. of
eaoh tissue were suspended in 30 ml of solution.

Henoe a oon-

.tanoy ot a 1.3 ratiO of inner to outer oompartment volume a wal
maintained in the ayat....

In so.e 1nstanoes, only two tlasue.

were employed for oompetltion experiments.
~t

Again the ltl ratio

combined inner to outer ohamber volume was utilized.
)

For an Indloat1on of the attluity ot CPZ tor the

tlssue, two experiments were oarried out.'; a) A d1alysis bag waa
oarr1ed through the prooedure 1 tor uptake.

After equilibriu.,
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the bag was removed, blotted dry with tissue paper, and transferred to a fresh ohamber oontaining only the bufter.
exoeeding the equilibriuM time period was repeated.

Dialysis
b) A tissue

with know CPZ oontent obtained from an animal administered OPZ.
was dialyzed against the butter, and also against a butfered CPZ
solution.

CHAP'l'ER IV
RESULTS
Recoverz

!! Chlorpromazine

~

Biological 1issues

The extent ot reoovery ot aPZ inoubated with brain
hOllOgenates wal lnvea tigated.

CPz, 2.$0 11110rogll. (13 e:x.perilllents)

and 25 miorogm. (8 experiments), was inoubated in 1.0 gm ot brain
The average reooveries were 81.6 ! 10.8 and 86.9.5 t

homogenate.

6.51 per oent. respectively (Table 1).
Speciflcitz

~ ~

Method

Thls chemical procedure was reported in thls laboratory
as being specitio for the intact molecule ot CPZ and its sulfoxide (67).

More extensive studies of spe.ltiolty were oarried

out at present.

!he method proved speoifio for the intaot pheno-

tbiazine rlng with the ohlorlne atom In the number 2 positlon,
and tor the corresponding sulfoxldes (Table 2).

Alterationa in

the 10-dimethylallinopropane side ohain did not alter the colored
reaotlon produot.

1he method did not distlngulsh between CPZ,

ohlorpromazine-X-oxide (CPZ-NO). seoondary (Norl GPZ, monomethylohlorpromazine) and prlmary amine (Nor2 CPZ) analogs ot CPZ, pro ....
ohlorperazine, perphenazlne, and thiopropazate (Table 2).

The

earlier results (67) suggest that sulfoxide. ot the.e oompounds
would reaot in a similar manner.
Ab8o.ption spectra of several phenothiazine. were investigated over ultraviolet (Pi. 2,1) and visible (Figs. 8,9)

Table I
Reaoveries ot Chlorpromazine f,,-om B1'8.1n Homogenates
(CPZ was added to bra1n homogena.tes 1:.3 for analysis)
CPZ
added

(mlcrogm.)

250
2$0
2.$0
250
2.$0
2$0
2.$0
250
2$0
250

2$0
250
2$0

2$

2S
25

25
25
2.$
25
25

CPZ

%

Mean ~

,..eoovered*

reo overed

recovered
± S.D.

225
221
1.$9
192
239
234
21$
215
236
262
232

90.0
88.2
6).8
16.1
9$.9
93.9
86.0
86.0
94.$
105.6
92.9
91.5

81.6 ± 10.8

Calorogm.)

229

186
20
18.75

22.8

21.1

22.8

22.2
2.3.1
2.3.

74.2

80.0

75.0
91.9
84.5
91.1
89.0

86.9.$ t 6 •.$1

92.4

92.5

*Value. are averages ot duplioate determinations

37

T -\'BLE 2

COLOR FORMATION BY lO-SUBSTITUTED PHENOTHIAZINES AND RELATED COMPOUNDS IN PRESENCE 01

H 2SO,

Fe+

AND

+- +

(XI Sx4~T
""

N

19-

R'

2

I

R

_ _-_ _ ~ ____ ~ E". values read at 10 to 20 microgm/ml.

Drug

R

C-h;-I;--o~rp~r~o~m~a~zl;--n-e

(CHJ,NMe,

Chlorpromazine 2° Amine
(SKF 4514 A, Nor, CPZ)

(CH,),NHMe

Chlorpromazine-N-oxide
maleate
SKF 6100 A

(CH,),JMe,
(CH,),NMe.

Prochlorperazine

(CH,),N

----~R~1------.~C~o7w~r----~E~.~,.--~

----~ ~ --~c1---C;o;-:-he~r~~~y-~re~d7 1-096 x 10'

°

/---',
N- Me

2-CI

Cherry-red

1-208 x 10'

2-C1
2-CI

Cherry-red
Cherry-red

I -092 x 10'
I -079 x 10'

2-CI

Cherry-red

0 ·927 x 10'

2-CI

Cherry-red

I 192 y 10'

Cherry-red

I -177 x 10'

2-CF,

OrangeColorless
Rust
Purple
Orange
Orange

0·206 x 10'
0·0
0'754x 10'
0-419 x 10'
0-404 x 10'
0-247 x 10'

2-CF,

Salmon

0·226 x 10'

'x_/
/-~'x

Perphenazine

(CH,),N

Thiopropazate

(CH,),N

N(CH,),OH

'x _~_/
/-'x

N(CH,),OCOMe 2-CI

'x_~

Chlorprothixenet
Imipramine HCI'
2-Hydroxypromazine maleate
Methoxypromazine maleate
Promazine
Trifiupromazine
Fluphenazine
Thioridazine

j

~CH(CH,),NMe,

(CH,),NMe,
(CH,),NMe,
(CH,),NMe,
(CH,),NMe,
(CH,),NMe,

/--'x

(CH,),N
N(CH,),OH
'x_~/

(CH.).-(~-->

2-CI
H
2-OH
2-0CH,

2-S-CH, Purple

1-005 x 10'

N-~

.j.
Me
SKF 5915
(CH) NMe
3-C1
SI Purple
1-142 x 10'
t In the case of chlorprothixene, C r:p;ace:::~s-;~:'-.----------------------------'-----------'In the case of imipramine, a CH.-CH. group replaces S.

0.0.

1.0

A

0.8
Thiopropazate

0.6

10y/m!.

0.4
02
0
1.2

B

1.0
0.8

Perphenazine
IOylml.

0.6
0.4

0.2

o
I

I

I

I

r

I

I

I
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Figure 12

Absorpt1on spectra 1n ultrav10let range for so••

phenothiazines.t

.

A. Th1opropa:&ate, B. Perphenaz1ne.
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Absorption speotra in visible range tor

phenotbia

A. 2-MethoxypromazineJ B. 2-HydroxypromazineJ C. Thiorida

sin.; D. Fluphenazine, E. Imipramine.
in~.

SODl8

Ordinate,
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optical density (O.D.).
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0.6
B

0.4
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Figure 91
thiazines:

4514A.

Absorption speo_ra 1n visible range tor some pheno-

A. Ohlorpromaz1ne-N-oxide; B. Thiopropazate; O. SKF

Absoissas

dens1ty (O.D.).

wavelength (I\.) in

mp..

Ord1nate:

optioal

Beokaan B Speotrophotometer was employed.

concentrations, 20 miorogm. per ml.

Drug

wave range (3$0-650

~).

CPZ-NO, thiopropazata, SKF

4S14-A

(Norl Cpz) and perphenazlne (Pigs. 7,8) whioh difter trom OFZ
only in substitutions on the X-alkyl ohain (Table 2) .xhibited
speotra similar to that of CPZ (Fig. 2); their colore4 reaction
products were Identloal, by vlsual observations, wltb the cherryred ohromophore ot CPZ.

Pigures 9A abd 9B show absorptIon spec-

tra for two phenothiazines, whioh while having tbe lO-dimethylaainopropyl group as the side ohain on the riag nitrogen, d1tterH trom OPZ 1n that the ohlorine atom in the 2 position 1s replaced by either a setboxy or hydroxy group.

It is apparent that the

respeatlv.absorption spe.tra d1ffered in the visible range.
Other substltutions for the chlorine atom in the 2 positlon also
resulted in differently oolored reaotlon produots.
thiorldazine (Flg. 90) yielded a purple

00101',

For example,

while promazlne,

fluphenazine (Fig. 9D), and tritlupromazine produoed varlous
sbades of orange (Table 2).

Also, substitutions of ohlorine .1....

where in the ph.nothiazlne nucleus led to reaotion
tering in color troll OPZ ('able 2).

p~oducts

Flnall,., Itl terations

i~

ditthe

moleoular struoture of the lIIhenothiazine nucleus, suoh as "PeDloval

ot either nitrogen or sulfur atOll, altered the chromophore •.
Cblorprothlxene produoed orange

00101".

Imipramine (Fig. 9E) re-

mained colorless in the prooedure {Table 2}, and its presenoe did
not intertere in the determination of CPZ.
Sinoe it appeared that the method was specifio tor 2chlorophenothlazine. with a N10-aide chain (2-CPN), this method

could be expeoted, in vivo, to assay OPZ and soae metabolites
struoturally related to it.

Aooordingl,., pertinent data pertain-

ing to the tissue distribution are expressed in terms of 2-CPN,
rather than CPZ, eveD when under oertain oonditions, only the CPZ
oould be expeoted to be pI'.sent.
The l'eaults indioate also that the extrllotion and
analysis method deseri.ed here oan lend itself, atter luitable
studies, to di:t'fettent1al ana.lysil of 011nioa11'1 important phenothiazine. other than CPZ.
'1'i.aue Distribut1o!

:2!

Ch lorprolll9.zine

Thirty seoonds after rapid intravenous injection of

OPZ,

40

microsm. per gm., 2-CPN concentrations in whole blood

varied betwe.}n ,300 and 500 miorogm. per Illl (Fig. 10).
aeoonds later,

oon~entratlons

per m1 (Fig. 10).
thia time.

ninety

were reduoed to 120-140 miorog••

Respiratory and oardiao arrest oeourred about

In the oase of oatl given CPZ b,. slow injeotion, the

levels of 2-0PN In the blood deoreased to 10.20 miorogm. per ml
within seven minutes atter ita administration (1'lg. 11).

'!'hil

level of 2-CPN in the blood remained essentially unohanged during
the subsequent tort,..elght hours (Pig. 11).

The earl1elt ana17sis of brain (oerebrum). heart, liver,
and lung was oarried out fitty aeoonds atter rapid administration
of CPZ.

High oonoentrations (0.8 and 1.1 mg, respeotively) of

2-0PB were tound 1n the heart and in the lung, where 2-0P5 waa
eater 1iha

4.3
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~
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tevels of 2-CPN in five seleoted tissues after slow

intravenous administration of

40 p..g/gm.

In all four plots, ab-

scissa represent bours (notice five ohanges in time soale) and
ordlnate--~g/gm of tissue (notioe that the oonoentration soala

ohanges from plot to plot).
tained

f~o.

Each point represents average. ob-

duplicate readin a in at least tw

4$
time (Table 3).

Liver and oerebrum exhibited levels of 2-CPN of

64 and 168 miorogm. per sm. respeotively (Table 3); these leve1$
were lower than those found at fitty seconds in the blood.

At

tour and six minutes, 2-0PN levels in the oerebrum (Table 3) and
other parts of the brain (Table 3) were muoh higher than in blood
thus, 2-CPK oontent of the blood, present in the tissue. investigated, oould not appreoiably oontribute to the total 2-0PN tound
In the tissues.

The level of 2-OPN 1n the cerebrum exhlbited a

transitory deorease from 168 m1orog~: per gm. at fifty seoonds to
111 mlorogm. per gm. at four to five minutes (Table 3, Fig. 11).
Maximum conoentration of 2-CPB tor the oerebrum appeared at about
forty.flve minutes.
d.olined slowly.

Thereafter, 2-0PN content of the oerebrum

At twenty-four and forty-eight hours, oonoen-

trations ot 2-0PN in brain were about 70 miorogm. per gm. and
30 mlorogm. per gm. respeotively.
Besides oerebrum, aeveral other brain areas were analysed tor 2-CPN at various time Intervals following OPZ administration (Table

4).

The oerebrum. hippooampus and various braIn

atem areaa had oonsistently higher OPZ ooncentrations than the
oerebellum, the difterenoes, while statistioally signifioant,
never exoeadeQ $0 per oent, and generally, were much le.s (Table

4); the ditterence. between oerebruM, brain stem and hippooampus
were even less marked.*

Also, the general pattern ot the slow

decrease ot 2-0PN level, following its 30-60 minute peak, was

* a..

appendix
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Chlorpromazine distribution in the cat
TABLE 3 TISSUE LEVELS OF 2-CPN AT VARIOUS TIMES AFTER ADMINISTRATION OF 40 f'G/GM Of CPZ
Average values in pg/gm. Numbers of cats per determination in paremhesis. Determinations carried out
in duplicate.
Tissue
Cerebrum
Heart

160

8

12

164

182

151

140

116

~3)

~I)

~2)

~2)

0)

96

69
(2)
160
(2)
162
(2)
86

1~ ~

(1)

(1)

205

190
(2)

53

58
(2)
101
(2)
185
(2)
102
(2)
145
(2)
128

83
(2)
36
(2)
242*

(I)

(1)

168
0)
779

111
(2)
459

157

0)
426
(2)
448
(2)
120

1122
64
(I)

Kidney

132

15

(1)

Liver

60

4-6

0)
Lung

Min
30
45

0·83

18

48

129
(3)
258
(3)
170
(2)
1<19
(2)
22

II)

0)

(I)

m

420
(2)
34
(2)
83

(I)

(I)

Fat
Spleen
Pancreas

(I)

128
(1)

194
(I)

0)

11
~I )

96
·(3)

80
(l)

0)

Hr
18

24

48

81
(2)
3"9

~2)

44

67
(2)
25

~2)

(I)

(2)

181
(2)
210

210

m

113
(2)

~2)

83

0)
30
(2)
87
(1)

94

54

48

(I)

(1)

(2)

32
18
(2)
182
(2)
68
(2)
25
(2)
25
(2)
34
(2)

131
(I)

Testes
Sciatic
Nerve
Diaphragm
Muscle'

80

66

(1 )

(1)

48
(2)

(I)

116

66

(1)

(I)

59

*An additional cat showed an unexpectedly low (40 pg/gm) lung content of 2-CPN. Values for its other
tissues were as expected and are included in this table.
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2-CPN AT VARIOUS TIMES AFTER ADMINISTRATION OF 40 p.G/GM OF CPZ (in p.G/GM)
All values represent duplicate determinations in single cats. Values for the cerebrum contribute to averages
in Table3, except for the 85 min value.

TABLE 4. BRAIN LEVELS OF

Hr

Min
Tissue
Cerebrum
Cerebellum
Brain Stem
Mesencephalon
Pons
Medulla
Hippocampus and
Thalamus

4

6

112
67
85

110
71

171
120

85

132

160

24

48

171

184

146

116
102
103

63
45

29
27
47

166

148

60

30
154
119

130
96

77

131

126
118
108
116

132

40

48
s1milar for the four brain areas 1nvestigated.
A high level of 2-CPN persisted in the heart for tifteen minutes after OPZ 1njeot1on (Table ) .

This level dropped

abruptly atter thirty minutes (from.more than 400 to about 130
microgm. per gm.) and more slowly thereafter (Fig. 11).

After

forty-eight hours, 2-CPN content of the heart was 18 m1\lrogm.
per gm. (Table ), Fig. 11).
Lung, like heart. exhibited very high levels of 2-CPN
1mmediately after its administration (l~l mg/gm).

The level was

still very high ten m1nutes later; 1t decreased abruptly to the
level of about 100 mio1'Ogm. per

"JUl.

within the next two hours.

However, unlike in the heart, this deoline was reversed; the
level of about 200 miorogm. per gm., reached at about 160 minute.
remained easent1ally unohanged for the subsequent forty-eight
hours (Fig. 11, Table 3).
Oomparatively little Z-CPN appeared in the liver during
the first six minutes after OPZ intravenous administration (Table

3). Subsequently, the liver Qontent of 2-OPN increased to a peak
which was some six times higher than the six minute value (Table
), Pig. 11).

After one hour, the level of 2-CPN in the liver

was as high as that in the cerebrum or lung.

It remained rela-

tively constant during the subsequent twelve hours; as 2-CPN
levels in oerebrum declined during that time interval, the liver
became, at twelve bours, the organ with the highest 2-CPN content.
Thereafter, the amount of 2-CPN in liver decreased rapidly; the

forty-eIght hour value was approximately 70 miorogm. per gm.
('ig. 11, Table 3).
During the tirst forty-rive minutes after CPZ administration, rat levels of 2-CPN were relatively

lo~

(Table 3).

Higher levels were reoorded thereatter, a peak value of
mioroga. per gm. was reaohed atter two hours.
tent of 2-CPN deoline4; the values of

46
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Then the fat oon-

and 2$ microgm. per ga.

were reoorded at twenty-tour and forty-eight hours, respeotively
(T.'lble 3).
Further analysis demonstrated that 2-CPN was distributed to pr.otioally

~very

tissue (Table 3).

'l'he spleen oontaine.

128 m1orogm. per gm. atter two hour., and the kidney oontaine4
almost 200 microgm. per gm.

aft~r

thirty minutes (Tabla 3).

After forty-eight hours both these tissue. showed levels at CPZ

at about )0 miorogm. per gm.
. The relative level of 2-0PN in tissue may depend on
the dose of OPZ; this possibility de.erved speoial attention in
view of the faot that the dose of

40

miorogm. per gm. would oor-

re.pond to the total dose of about 2.8 gm. in the buman, whiob I.
high tor a single dose in a human.

Levels oT 2.CPN were measured

in two oat., one hour after the intra.venous administration ot 20
miorogm. per gm. of OPZ.

The average 2-CPN oonoentration in

various tissues was (in miorogm. per gm.):
kidney,

75;

lung, 124; liver, 97;

heart, 49; blood, 10; inguinal tat,

14;

oerebellum, 91; midbrain and pons, 76; medulla, 6).

oerebrum.

94;

The •• levels

SO
were generally somewhat higher than those that oOllld be expeoted
on the basis ot besults obtained with the larger dose.

The gen-

eral trend was similar with both dosesJ 2-CPN aooumulated in the
lung. liver, kidney and the brain atter the smaller dose as it
did after the larger dose.

Cerebrum exhibited the highest 2-CPN

level among the parts of the brain investigated, as in the oase

ot 40 miorogm. per gm. dose of CPZ the ditterence. were not
marked.
Pharmaoolosio Findings
gross pharmaoologio effects were observed in

~ne

thirteen cats.

Shortly after the start of the injeotion of OPZ,

40 miorogm.per gm., the animals beoame relaxed, the respiration
depressed, and the pupils dilated.

Applioation at the htullostat

clamp onto the tailor the toe pad produced no response.

Thus,

the animals resembled those in plane 2 or ), stage III, of ether
anesthesia.

Twelve hours atter OPZ administration, painful stim-

uli caused no ilnmed1ate response.

Upon repeated stimula t:1(\n a

dela1ed response oocurred} the Qst withdrew the paw or the tail,
and emitted a weak cry.

Even thirty hours after OPZ administra-

tlon, the oat still responded to paIn stimulI with a oharaoteri .....
tio

3-5

8800nd delay.

Forty-eight hours after CPZ administration

the response was immediate, but the slight cry and attempt to
move the afflioted 11mb were not aooompanied by aggression.
Co-ordinated motor aotivity was absent ten to eleven

hours following the injection of CPZ.

The righting reflex was

poor or absent for approximately twenty-four hours.

However, at

twelve hours, two of the thirteen oats made attempts to lap milk
or to

~alk.

Interest in these aots waned rapidly.

into the cage usually was not eaten

fo~ty

Food placed

hours after the Injed-

tion ot OPZ.gven forty.eight hours after receiving medioation,
the animals exhibited no sustained motor activity, and mainly
rested or slept, agression and resistance to
or handling were absent.

~ough

manipulations

Relaxation of the niotitating membrane

was appa.rent for more than torty-eigbt hours.
In the study ot the hypothermio aotion ot 6PZ, tour
unmedioated oats, restrained for seven to twenty-tour hours, revealed lIluimal reduotion in rectal temperature of
(Fig. 12), whioh ooourred
hours.

af~er

Immediately upon their

.4.2 t

0.9 F.

immobll1zation ot about four
rele&~e,

the temperature roae.

Levela recorded prior to the restraint were a.ttained in .about an
hour.

CPZ.

40

miorogm. per gm. intravenously, was administered

to these animals restrained 1n a harness.

The cats were released

from the harness two hours (1 animal), eight hours (2 animals),
and forty-eight hours (1 animal) atter medication (Fig. 12).
Maximal hypothermia was 8.6 t 1:06

H; it oocurred independently

ot the t1.e ot the te-"mination or the restraint, eight to twelve
hours after medication.

Altogether,

-.

c~~

hypothermia was abuut

double that produced of restraint; sinoe at the end of hypothermic
erteots (24-32 hours atter medioation) the oats, while motile,

I
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were still sedated, it is diffioult to aay whether or not hypotherala was seoondary to sedation.
Equilibrium Dialysis Stud:

~

Tissue

Bindi~ ~ ~

POl" purposes of clarification pertaining to the observations obtained by equilibrium dialysis it is neoessary to define the terms "unbound", "bound", and "uptake".

Unbound drug

reters to the drug whioh has not entered into a oomplex with
either the tissue homogenate proteins, enzyme., or oellular oomponents, or the oellulose casing employed in these experiments.
Unbound drug oonoentrat10ns are those found from analysis ot the
outer compartment.

The usage of the term "unbound" drug a8 op-

posed to "bound" drug shall be employed in this text.

The term

"bound" drug shall reter to the difference in oonoentration
(Dd.orogm. per ml) of the drug in the inner and outer compartments, providing of oourse, that the inner cha.mber exhibits a.
higher oonoentratlol'1 than the outer ohamber.
if equilibrium has been attained.

This applies only

The per oent bound drug will

refer to the ra.tio ot the amount of bound drug to the amount of
drug found in the il'1ner oompartment at the end of the experiment.
The term "uptake" employed in the text refers to the amount of
CPZ, bound and unbound.

~vhioh

had been found inside the dialysis

bag at the termination of that partioular experiment.
Effeota·ot !himeroaal
Aliquot8 plated tro. the preliminary equilibrium
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dialysis experiments revealed a number of baoterial oultures
whioh grew in the outer ohamber ot the reaotion vessels.
tioation of these baoteria was not attempted.
growth oan introduoe unknown faotors and

mar

Identi-

Sinoe baoterial
result in the metab-

olism or oxidation ot the OPZ moleoule, it was deemed advisable
to seleot some suitable substanoe or technique to eliminate possible baoterial interrerenoe.

Perrormanoe or experiments at low

temperatures reduces the rate of baoterial growth.

However, the

tnaooessibility or cold-roo. faoilities required the utilization

ot other teohniques.

The introduotion of thimerosal at the tinal

oonoentration ot 0.16 mg
in these experiments.

~ (O.OOOl6~)

eliminated baoterial growth

Table S shows that tull reoovery of' CPZ

was etrected in the presence of thimerosal.

Tests tor baoterial

growth atter the introduotion of thimerosal solution in the reaotion vessel were negative.

Theretore, baoterial plating waa

not performed routinely.
ThuI, thimerosal did not change reoovery as shown in
table 1.

The lower OPZ recovery from the experiments laoking

thimerosal (Table

5)

may possibly be suggestive that OPZ may be

metabolized in tne presenoe of baoterial strains.

This interenoe

must be interpreted with caution ainee no attempt was made to
pursue this observation; furthermore, ph.enothiazines have been
known to reduoe baoterial growth (68).

Reooveries observed in

the presenoe of baoterial growth (Table 5) were not signifioantly
ditterent trom the lower limits of the reoovery reoorded in

5S
table 1.
Table

S

!he Effect of Thimerosal on the Recovery at Chlorpromazine
during Equilibrium Dialysis
Brain homogenates (1:) were dialyzed for 20 hours at room
temperature, pH 6.8. Volume of solution in outer chamber,
30.5 mll inner ohamber volume 4.5 ml. Initial CPZ oontent,
8790 microgm.
Thinaelto.al

L
I

I

(ml)

t

CPZ Reoovered
Inner I Outer
Chamber I Obamcar
(A)
(B)
I

'lONE

3546

0.5

5148

Binding

~

I

I
I

;

~g)

Total

!C Recovered

(A+:!)

3)60

6906

78.6

)812

8960

101.9

Diallsi8 Bas

Consideration was given whether CPZ would bind signifioantly to the d1alys1s bag.

To asoertain the error whioh may be

introduoed by the binding at CPZ to the oellophane bag, determinationa of CPZ tram both, the inner and outer, ahasbers were
performed, total CPZ estimated and the reoovery oaloulated.
Table 6 shows that the reooverie. obtained by analysis at both
inner and outer solutions from a series ot experiments averaged

98.$7 per oent.

This indioated that the binding of CPZ to the

oellulose caslngs was negligible or reversible.
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'fable 6
Reoovery ot CPZ Following Equillbrium Dialysis
Brain homogenate. 1:10 were dlalyzed for varylng time perlod.
at room temperature; pH 7.12. Volumes of solution in outer
ohambers equal )0.5 ml., Inner ohambers volumes, 8.0 ml.
Inltial CPZ oontent 10560 microgm. in each tube. Mixing
produoed by magnetl0 stirrer.
Dlalys1s
Duration
(Hours)

CPZ Reoovered (mlorosa)
Ou;er
Inner
To"a].
Chamber
Chamber
(A)
(B)
(A+B)

Ditferenoe
~
trom in1tial Dltterence
oonoenlrratlon
~

1

6889

1381

10,270

-290

-2.74

2

8697

2130

10,827

267

2.53

4

6780

3624

10,404

-156

-1.48

6

6039

4512

10,551

9

8

3715

6372

! 10,087

-473

- .08
-4.48

16

3556

6657

1

-241

-2.31

I

10 ,213

-

,
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Ette.t

!!

Varying Q!!

conoentratlon~

High Initial oonoentrations of the drug could establish
an equI1Ibriua whioh would saturate the inner hOMogenate solution
to the extent that the existence of binding would not be reThe etrect ot inoreases of the CPZ oonoentration oJ the

flected.

bInding by oerebrum homogenate. (1:100 dilution) resulted in a
lineer., inorease in uptake at four hours (Fig. IJA) and at six
hours (Fig. l)B) tor CPZ oonoentr.f!tiona investigated.

No experi-

ments were oarried out in which the initial CPZ oonoentration w••
increased to the level at whioh further inorements resulted in
no greater uptake of CPZ by that partioular homogenate conoentraSinoe a oonoentration ot 1 mM did not appear

tion.

~o

be near

the limiting conoentrat10n tor CPZ uptake. this oonoentrat1on
was employed 1n

Ette.,

!£

subsequentJ.x.pe:"i~ents~

Difterent M1xins Teohnique.
Equilibrium in the oontrol experiments was atta1ned at

approximately six hours when the magnetic st1rring bar (Fig. l4A)
or the Eberbach shaker (Fig. 148) oonstituted the method for
m1xing.

Comparison of the two shaking methods ror the binding ot

OPZ, employing 1:100 brain homogenate., revealed that a alight
ditterenoe ocourred in the time to atta1n equilibrium (Fig ••
B) •. By

l4A,

means ot the magnetio stirring meohanism the uptake pro-

o.eded somewhat slower than that obtained by the Eberbaoh shaker.
Al.oateight hours were required to atva1n equ1librium by the
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Brain Homogenates 1:100

-

300

A

t:

Q)

-

E 200

4 hours

~

0

c..

E 100·

0

U

Ii

~

Q)

t:
t:

-

E 300

B

~

Q)

c..
N
Cl..

6 hou rs
200

()

0'

E
.,

100

Q)
~

0

c..
:::>

o

0.2
0.4
0.6
0.8
Initial CPZ concentration (mM.)

.-'

Figure 13:

Effeot ot<"arious OPZ conoentrationa on uptake b'1

oerebrum homogenate. (1.:100).
r1um).

A. Uptake at

B. Uptake at 6 hrs. (equilibrium).

oontrols
Abaolaaa:

a

and homogenate 0 •
In1t1al OPZ

er ml 1n

4 bra.
~.

(pre.equ111b-

• repre.ent
ourve.

Room •• mperatur•• pH 7.12.

t,oncentra.t~on

1n MM.

ordinate:

uptake,

800

x

A

S9
Cerebrum (I: 10 homogenates)

600

400
Cerebrum (/' 100 homogenates)

c:
Q)

E
~

200

Control

0

a.

E

0

0

u
~

Q)

c:
c:

-800
Cerebrum (I: 10 homogenates)

--

-

E

600

~

Q)

a.
N
(L
<.)

400
Cerebrum (I :100 homogenates)

E

0

~

CJI

0

200

Control

~

u

E

0

Q)

-

..x:
0

a.

400

•

C

=>

Cerebrum (1:100 homogenates)

200

0

4

8

12

Duration in hours

Figure 141

uptake of CPZ by oerebrum homogenatesl

A. Room tem-

perature, rrdxing by magnetio stirring bar; B. Room temperatnl*e,
mixing by Eberba,b shaker} C. At 0-4
81'.

0

C. m.ixing by Eberbaoh shak-

The ourve. repre.ent oontrol a •• ~mblie. 0, homogenate. 1:100

•• and hOllogenat •• 1: 10

hour., Ordinate:

U

x,

at pH 7.12.

.Absoissa:

Durat10n in
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former technique whereas equilibriuM was attained within six
hours using the latter shakIng mechanism.
figures

l4A

From exaalnatioD ot

and 148, it may appear that the magnetio stirring

technique resulted in

greater uptake of CPZJ however. tt-is

I:l

ditterenae was within the range of variability ot tha analytioal
method employed.
Ette,at

.2!

Temp.ra~

.2!!

m

Uptake

The seleotion ot lower

te~peratures

to pertorm equilib-

rium dialysis by i.Uos't investigators stems trom the knowledge that
lower temperatures tend to limit or reduce protein hydrolysis and
. denaturation or enzyme destruotion.

The uptake of CPZ by tissue

(oerebrum) homogenates was measured in the presenoe ot thimerosal
at 0-4

"c and at 24-26 0

0 (room temperature) ..

ApPl'Opriate controls Were performed in both experiments
The oontrols at the two temperatures attained equilIbrium at
approximately the same time.

Equllibrium for cerebrum homogen-

ates (11100) oocurred at about eight honrs at 0-4
and wit!tln six hoUl's at 24-26°0 (Fig. 148).

C

C (Flg.

140),

Little differen ••

in the uptake of OPZ at equilibrium was evident at

th~se

two

temperatures (Figs. 14B and l1.e). althQugh the period to attain
equilibrium was longer at the lower temperature.

Somewhat simi-

lar effeats of temperature upon the binding of other organI0
oompounds had been reported by KIGtz et ale {58} and Da"lison and
Smi t11 (60)..

Evaluation of the kinetios ot temperature etfeat waa
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Efteot

2!. Tissue Homogenate Concentration
An increase In the tissue homogenate oonoentration 1n

the inner chamber resulted in a greater uptake of CPZ (Table 7).
A ten-fold inorease of homogenate concentration resulted. in an
uptake that was almost doubled.

Thus, oerebrum homogenate.,

1:10. exhibited a mean uptake of 773 ! 53.5 miorogm. CPZ per ml
as oompared to 407.3 ± 21.6 miorogm. CPZ per m1 tor oerebrull
bomogenates 1:100.

T~e

per cent

b~nd

CPZ also increased at

higher oonoentrations of tissue within the homogenate.

Thus,

1:10 oerebrum homogenate dilutions exhibited approximately 87.2 t

2.95 per oent bound CPZ as compal'ed with 55.1

t 2.02 per cent tor

;

1:100 oerebrum homogenates (Table 7).

---

Eftect ot Aged and Boiled Cerebrum Homogenates
Cerebrum

homogen~~es

jeoted to heat.ing at 90

0

ot two oats whioh had been sub.

C revealed no apparent (Utterenoe in the

uptake ot CPZ compared to unheated homogenates (Table 8).

Also,

oerebrum homogenates aged from two to four weeks exh1bited uptake
o~

CPZ essentially similar to that ot the tresh11 prepared homog-

enates (Table 8).
Efteot ExhibIted

Ez

Various Tissue

~_omogenates

Uptake ot CPZ ooourred tor all the tissues studied,
inoluding blood.

It was found with the

pre~ent experim~ntal

oonditions that 1:100 homogenates ot liver, brain, heart, and
lung were capable ot interaot1ng with CPZ to

approx1mat~11

the
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Table 7
!he Eftect 01' Varying Concentrations ot Tissue Homogenate
Preparation Upon the Uptake of CPZ

outer solution volumes 30.5 mil inner solution volume 10.0
ml; pH 7.l2. Cerebrums rrom two oat. were used. Each
dialysis duration ex••• d. tbe equl11briua period.
,-!

Homogenate
Oonoentration

:
I

I
I

! Dilution

-,- - - .

I Dialysis
j CPZ oonoentrations
Duration
miorogm. per ml*

r-"-----r---"----

gm. wet wgt.
tt •• ue/ml

I

~

Bound

Inner,
I Chambep Chamber
!
_ (Uptake)
I

I
i
I

outer

CPZ

I-

i

I
!
,i
i

!

I

1,10
1:10
1:10
1:10
1:10

0.1
0.1
0.1
0.1
0.1

I

r------

i
I
- - _.-,--"

i

I

6
8
8
8
16

1:100
1:100
1:100
1:100
1:100
1:100
1:100

,

j

,
!

1

j

i"

~~Each

I

6

0.01
i

0.01
0.01
0.01
0.01
0.01
0.01

i

8

16

18
24

24
24

r---I

~

-

7)
73
117

!
;

I

i

i

192
191+
172
175
175
192
rl9

}ligAN! S.D.

84.8

716
792
717

122

j

MEAN + S.D.

---'----"

~,~,~--

109

I
"

':

t
. i~

~"

,
I

I

!

84.7

89.8

808

832

91
85.9

1'13 ! 53.5

87.2! ~.95

--

402.5
410
)90

52.4
52.5

399

56.1

56

401

i

394.5

,

454

I

5b.4

57.7
54.7

407: 21.6 155.1 ± 2.02

figure is the average of duplicate CPZ analysi.

,
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'1'ab1. 8

uptake ot OPZ by Oerebrua Homogenate. Subje.ted to Various
Treatment
Brain homogenate. 1:100 were used.

outer solution volume.,
Initial

,30.5 ml; inner solution volumes, 10.0 m1; pH 7.12.
OPZ oonuentration averaged 346 miorogm. per ml.

Souroe of
Homogenate

Experiment
Duration
(Houl's)

I uptake

Conditions

ot

of CPZ

*'

( moroga/vJl

I
Temp ... Stirring ·

Experiaent

---.---------+----------+-----~--------~------------~

Oat #1
Fresh

6

Room

Hagnetio,

3.50!

Aged

6

Room

Magnetic

324 t 21

Ballad

6

Room

Mllgnet10

-.~--

. -.+-----.-.. ..... ~

Cat fl1

FJ:ge.h

Boil.d

. -..,.- ,-.. .

Room

.386

454! 1

Magnet!o

2

,I Eberbach
II Room
Room 'Eberbaoh:

264 t

5

238!

4

r-a-R-t-#~2----+-------·~I-----+-------r----------

Fresbr
Boiled
Cat 12

Fresh

Ebarbaon

I

358

Room· Eberbaoh

t

311

4
4

Room

6

Room

:

I

±

2.

t

Eberbacn

,-f

401!

9

r

Boiled
cat 112
Frosh

I
I

47_0_:_1__ 1

_D_•.__
t_l,_o....:-_.__

2.

I

...., - - , - . - - - . - ,

,-.-""'-~,,".'"

' Roo,m_--1-1M_tlg

Boiled
Oat I/Z
Preab

..

~-.- ~-

i

3

6

Room

Eberbaoh

I

402

24

0-4°0

Eberbaoh

I

417 i

2

Bo_il_e_4_ _ _ _24
__---:..I_O_-4_o_o__JJ_be_l"_b_a_O_h_'_ _4_2_2---

1_ _

*Pigures inolude average t range (a minimum ot .2
analyses for each figure).
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s . .e extent (Figs. 140, 15A, B_ C).

With all tiISU •• , the maxi-

DlUm uptake at room temperature ooourred at about six to eight
hours.
'Whole blood, diluted 1:10, whioh contained heparin as

the antiooagulant, exhibited an uptake of CPZ whioh diftered
trom that obs<::rvod with the other tissues.
uptake and the

~er

Table 9 compares the

cent bound CPZ dt the blood obtained from one

oat to that or cerebru. lslO and oerebrum 1:100 homogenates prer
pared tram another oat.

When whole blood, diluted 1:10,

oonstl~

tuted the inner medium, blood extrl.blted an uptake le88 than that

found tor a similar 1:10 dilution tor brain homogenate.

A muoh

lower uptake was antioipated, beoause of the results in vivo,
indioating that l1ttle CPZ was reta.insd in blood.

The uptake and

per cent bound OPZ observed in blood, diluted 1:10, in vitro, ma7

be oomparable to the lower dilution (1:100) ot the tissue homogenat •• (Table 9).
One experiment "'.las pert'ol"lIed whereby ttndiluted. h\tparin1.8d blood, to which Cl'Z was added, constl tutttd the so1u·tlon of

the outer chamber.

Tbe design of the ,,;Xi)SItiment was similar to

that desoribed for competition between the

tiss~es

for CPZ, that

Is, four tlssuft homogena.tes oonsti 'tut~d the inner ohambers.

'rhus

10.0 1Ul homogenates (1:100) of ear.brunt, heart, livel-, an4 lUng
vere suspended in separate d1alys1s ba.3S in 96 '1ll ot the heparin-

ized blood.

Fo1" eaoh tissue, tht) uptake par m1 ot homogenate

(Table lQ) vas. in this expertmentl, approximatel., 10 per oer.rt ot

6S
0

400

0

300
200

-..
-..

c
100
E
0

LUNG: (1:100 homogenates)

0

Q.

E
0

..

0
0

~400
cC

....: 300

..8-

E

LIVER: (1:100 homogenates)

N

Q.

0

..

1

~

..

00
0

u

'E

.I0

0

-

400

Q.

=>300
,
Heart (1:100 homogenates)

200
100

I

0

Pigura 15:

hours,

4

6

12
10
8
Duration (hours)

14

16

18

i
20

Uptake of CPZ by tissue bomogenates 1:10-); A. tung;

B. Liver; G. Heart.
sbaker.

2

Mixing etteoted by Eberbach variable speed

Roo. temperatura, pH
O~dinat.:

7.12. Absoissas

Duration in

Uptake; miarogm. CPZ per ml inner oompartment.

'fable 9

Uptake of CPZ by blood, in oompa.risOJl to aerebrwa. homogeDat.
Outer a~lution volumes, lO.5 mll inner solution ~olumea.
10 ml. pH 7.12. Initial CPZ conoentration 3$0 miopogm.
per ml~ Mixing b7 magnetic st1rring ba..
Tisaue

Exper1llen t
Durat10n
(Houra)

Uptake

ot

CPZ

(udcrogm/ml)*

%

Bound.

CPZ

Control (ECj,1.li11br1u.)
.
Whole blood lrl0

6·

232

t 13

6

334

t

18

47.4

Cerebrum

1,10

6

64.)

O.Hbrum

1:100

6

S64 ! 18
3S0 ± J

40.4

18

~l07

60.3

WAole

blood 1110

!

,

aare'brWl

1:10

16

8)2

85.9

Ca•• bru.

1alOO

18

)99 t 10

S6.1

*FIgura. inolude averaga t l'anse (2 ana.l,..e. per each
figure) •
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the

Ini~lal

CPZ oonoentration ot the blood--a level tar less than

that expeoted trom the comparison of the results obtained in vivo
where very little

CPZ

was

fOlmd

in the blood because the tissue.

exhibited signifioant uptake (.ee results p.

44).

Thus, OPZ was

not bound by the tissues when undiluted whole blood constituted
the outer •• diu. of the equilibrium dialysis chamber.

!able 10
Uptake ot

CPZ

by Various Tissue Homogenate. in the Presenoe ot
Blood

outer solution oontaining )68 ! 7 microgm. CPZ per ml oonsisted
ot 96.0 .1 hepar1ni.ed Whole blood plus 2.0 a1 thi.erosal. The
d1alysis bags contained 10.0 ml ot the respeotive tissue homogenates (1:100) in phosphate bufter, pH 7.12. Duration ot experiment 6 hours at roo. temperature. Mixing etfeoted by magnetic
stirring bar.
Tissue
HOllOsenate

312
Cerebru18

LiYel'
Lung

)2.0

68
Sinoe 1 ·mM

oonoent~atlon8

ot CPZ preoipitated in

phosphate butter at pH 7.4, CPZ ma1 have preoipltated 11'1 the
blood (pH 7.4), an etteatwhich would aftect the results.

How-

eYer, under the experl.ental oonditions, the pH ot the blood at
the termination ot the experiment was 7.2.
Ufeot

.2!

ooewetltlon

2!

Tissue.

'.1"0 detern:tne \ihether oOlllp3tl tion between the various

tissues oocurred in vitro J dialysis ba.gs oonta.lning the . tissue
homogenate were suspended in a beaker ot buffered CPZ solution
10

that the ratio 1;.3 total homogenates to buttered

e.s

l~

the uptake

experiment~

(sea Mothods, p •

.3.3).

~PZ

prevailed

At the d....

ignated intervals aliquots uere Analyzed as desoribed under proaeduNs.

'tho results of these experiments are shown ltl Table 11.

Uptake of CPZ by each of thasQ tissues appeared tp b.

sl~lar.

Further experimentation is neoessar,. to determine whether the
slightly larger uptake ot CPZ exhibIted b1 liver homogenate. 1.
atatistioally signifioant.

Thul, in theae experi••nta, the dif-

teren.e. in tissue uptake observed in vivo did not ooour.

Attialt: !! cerebrum aomogenates

~ ~

To teat tor affinity of the tissue for CPZ, duplioate
equil1brlua dlalysis assemblies were prepared.
served as • oontrol.

One assembly

The bags were removed at the same t1me;

one of the bags was blotted dry on tissue paper arid resuspended
in a oba-oer of tresh phosphate butter lacking CPZ.

Thi. new
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Table 11

Uptake ot CPZ by VarIous TIssue Homogenate. In CoapetltloQ
with eaoh other

All tissue. were prepare. as 1:100 homogenates. Buttereel OPZ
so~ution. pH 7.12. oonstitutod the outer chamber (8ee .ethoels).
Tissue
Homogenate

I
I

!

i
----,----·,----·f,----,,,>-··->,··-·,·
!
Expt. 1
I
CEll'e brUlll !
Heart
I

,

'\

ExperiJlent
l)uratlon

6

I

r
!

Cone 1 n

9~O~Z

(microgm/m1)*

InIt!a1

Pinal

,.~-'",---,------"'«,".-

. ,.,. ,. .,., r"

197 t 1

325

Lung

,I
I

I
Cerebrum

Heart

Liver

Lung

..sxpt. .3
Cerebrum
aeart

!

4

I

Expt. 5
CerebrUJll
Heart
LivexLung
Expt. 6
Cerebrum
Hear1l

II
I

178 ± 4

372 ! 6

I
I

I

168

1 ,
!

451 ! 9
462
S06 ± 26

!

417!

!

I

i

18

-

372 + 6

I

-

172 + 1

I

I
I

20

I

336

316

.38!}.

!

18

163 !' 3

! 8

I

458 ±

444

t

-

I

Liver

1

Lung

*Figures include ave~age
per eaGh figure).

168

± range

,

i

5 ,
~

i

21

25

I
i

!
I

i
I

40~

*14
-

3.34 !

.336 + 8

~

i

39
430
20

2

! 6
398 ± 2
362 ! 1.4

I

I

I

OerebruDl
Heart

3)6 ± 6

I

Liver
Lung
Expt.

6

1
I

,

384 ~

2
14 t 16
344 ~ 32

, iI

bpt. 2.

Oh.mber

,58 ±

1

Liver

-

Inner

OutEn" 1 edium

1
4

~99 ;!; :5
02 ± 5
410 ! J
314 : 10

(result. for 2 analyses

I

II
iI
I
I
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asselubly was dialyzed for another period (see table 12).

Butter

oontrol as.emblies, that is. the inner oompartments containing
butfer solution only, were subjected to the same prooedure.

The

butter control showed the establishment ot a second aqul1ibrium

following the initial upt9K8 experiment.

This indicated that the

dia17s18 bag was not damaged by the prooedure which· nUIlY' have re-

sultad

~n

an interferenoe wi th the movement ot the CPZ outw8.Jtd

from tbe bag.

The results of tour experiments oon1itl1nlng oerebrum
homogenatt18 are shown in table 12.

From these assemblie. it was

observed that the unbound OPZ, pre.ent in the physi.cal 8')lut10n

ot tbe tissue homogenate,

~hioh

constItuted the amount of OPZ in

equilibrium with that ot th3 outer solution of the first assembl,.
moved aoross the membrane of the dialysis bag to reelltabl:tsh an
equilibrium.

The remainder ot the OPZ wlthin the oonfines ot the

tissue oompartment, that 1s, the bound CPZ

(~abl.

12, oolumn D)

.ust have eXhlbited an attinity to the tissue (Table 12, colurrltl

H).

Otherwise, slnoe a concentration gradient was evident, equal

amount. of OPZ should have been found in the inner and outer
solution

or

the second dialysis assemblies.

The latter did not

ooour (Table 12, compare oolumna F and G).
Furthermore, when the inner oom.partment oomposed of a
homogenate (ltlO) prepared from the cerebrum of a oat given aPZ
in vivo was dialyzed agalnet

phosph~te

partment. it was observed that

th~

hurfer in tho outer oom-

already bound CPZ was not
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TABLE 12
AFFINITY OF CEREBRUM HOMOGENATES FOR CPZ.
OUTER SOLUTION VOLUMES OF BOTH ASSEMBLIES WERE 30.5 m1.;
INNER HOMOGENATE VOLUMES WERE 10.0 m1. ROOM TEMPERATURE. pH 7.12

i

INITIAL DIALYSIS
CPZ CONC'N. ()Jg/m1)
*UPTAKE
DURATION
BOUND
*OUTER
INNER
(HOURS)
CHAMBER CHAMBER
CPZ
(A)
(B)
(D)
(C)

iCerebrum
1:100

*** ..
***..

Cerebrum
1:100

6
6

Cerebrum
1:100

6
6
6

Cerebrum
1:100

r
IDIALYSIS
BAG
ICONTENTS

I

!

Buffer

358
357

SECOND DIALYSIS
i TOTAL AMTS OF CPZ ()Jg)
CPZ CONC'N ()Jg/ml)
DURATION
(HOURS)
(E)

flOUTER
"'INNER
CHAMBER CHAMBER
(F)
(G)

BOUND
CPZ
(H)

INNER
CHAMBER

OUTER
CHAMBER

(J)

(K)

193

16 ..

16

172

60.6

111

1720

18 .. 8

3..... 5
**362

231.5
235

113
127

16

176

61

115

1760

1860

3"5.5
**352.6
**351.3

205.8
203
20..

HO
150
1 .. 7

16
18

188
188

53.8
53.7

13..
13 ..

1880
1880

16"1.1
1638

18

**.. 08

169.7

238

6

257

"9.7

207

2570

1512

6

**230

23 ..

--

16

53.3

52."

* Each figure includes the average of two analysis for CPZ.
** These figures are estimated from analysis of inner and outer chambers of the second dialysis assembly.
These figures multiplied by 10 (the total volume of the inner chamber) are equal to columns J plus K
of the respective experiments.
*** This experiment was terminated prior to equilibrium.

72

r.le •••d into tbe outer oompa.-.ent (!able 1).
o.reb~u.

Thi. particular

oontatned pharmaoologioal 81gnltlo p nt nmounts .of r,PZ;

that ls, 104 t1&lo1"oSIR. OPZ per

gil • •Il.

found to11ow1rlg the In'N-

••noua injeotion ot CPZ (analysIs of the hn!'flogen'lte, 1110, prepared

t~

this tissu., Indicated 10.2 mlorogm. OPZ per ml ot

ho~s.nate).

This oerebrua

w~s

Alao

o~pabl.

trat10n ot OPZ, in vitro (!able 13).

The

or

upt~e

turther oonoen-

ot CFZ atter

tVeat1-tour hour8 ot d1alY818 va. 791 miorog_. per al.
eel tbat the combinations tormed by

onz

and the tisaue

It appear110"

rather tirm.

'1abl0 13

Dlal,81. ot O.r.~rua fpo. cat 1Iblob bad b.en Administere4
IntI-avenous apz

.1, lnne.
801utlon .01....
pH 7.12, roo.

out•••01ut1on "olu... woro )0.5
ot homogenat •• , 1110, were 10.0 ale
souoo

Dlall81.

J)Uratloa

r

(Boul'. )

!
~

,

'o~er.turo.

o.ter __041ulI
Inlilal
Conoto
(m.loresm
per al)

content,

,..-....."'-----.

,.-.~,~

"--_._---------_.- -

Con.tn

QllZ

Inner

801u'io.

(lIdcrcgm

p•• 81)

Ce..br.

16

Butt•••4 CPZ.

lsa

8)2

"O.1".-'u.
*O.".wua

24
24

SUtt•••4 OPZ

344

791

,

BlItt••

*tal'.&1 CPZ oOllteDt 104 aUoroSa. per gil.
ti.sue homogenate, 10.2 .1oroa-. r.~ mI.

0

10.1

hal,.81. of

CHAPTER V

DISCUSSION

SpeoifioitI

~ ~ ~

Method

Recoveries ot OPZ ot almost 90 per oent were obtained
by means ot the desoribed prooedure for the quantitative analr8is
ot OPZ trom biologioal tissues based upon the extraction ot OPZ
trom alkalinized ether and the subsequent oxidation ot CPZ
terrio ion in the presenoe of sulfurio acid.
this prooedure were:

br

The advantages ot

1) speotrophotometrio readings may be ob-

tained in the visible range, thereby eliminating the correotions
tor tissue blanks whioh are required in the ultraviolet methods;
2) reooveries of CPZ iro. animal tissues, espeoially brain, were
greater than those previously reported ()9,48).
The prooedure appeared speoifio for CPZ and other 2ohlorophenothiazine. possessing a side ohain on the ring nitrogen
One point to be clarified 1s whether or not the material referred
to in the RESULTS a. 2-chlorophenothiazine with a N10... ide ohain
(2-C1N) __y represent chlorpromazine itself, or include also the
metabolites of CPZ.
Metabolism ot OPZ haa not been tully clarified.

Sulf-

oxide. (69); oompounds altered 1n the N10-alkyl ohain (70-72) and
and N-oxlde of CPZ (7)); monophenols (14.75) and oonjugated mater
lals (47,74,76) were identif1ed as metabolites ot CPZ.
pounds represent, depending on spe.le., trom 22 to

35 per oent
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ot administered CPZ (17,78).
unohanged (77,78).

the tate

Relative!',- little OPZ is exoreted

.r

trom 60 to 80 pel" oentot OPZ is

not known.
!he method employed reveal., besIde. CPZ,

obl~rlnate4

phenothlazines diftering from OPZ 1n the N ohain, as well a8
their sulfoxidea; 1t doe8 not asaay oompounds with major ohange.
in the phenothiaz1ne ring, with substitution for ohlorine in the
2 position, or with ohlorine preaent elaewhere In the ring.

Thua,

the asaay may have measured, bes1des OPZ, the metabolites de.orlbed above and perhaps unidentlfied CPZ metabolites, provided they
are olose analoga of OPZ.
Slnce gluouronide oonjugation does not ooour in the oat

(79,80), the presenoe ot CPZ-gluouronides in the.e analyse. 1.
unlikely.

Reduced pharmacolO;ioal aotlvity e:xblb1ted by some of

the C?Z metabolites have been reported.
uct. ot OPZ exhib1ted deoreased

The sultoxidation prod-

pha~aoologioal

activ1ty (81-84).

BorlOPZ showed only slightly le.aer aotlv1t7 than OPZ, but the
primary amine analog, lfor2CPZ, exhibited pharmaoologio aotion
about equal to that of CPZ.

OPZ-IO was found le88 effeo1;lve

pharmacologioally than WorlcPZ (8).84).

Sinoe

~.duoed

pharmaco-

10g1c ettec's may be antioipated from aome of these derivative"
there appear8 le88 likelihood for their presenoe.
On the other hand. metabolite. generally do not rems.ln
in the ti8SU.S tor long and they oan be expeoted to appear rapidly in the blood.

The faot that only low levels of 2-CPN were

7S
found in the blood, suggests relative absenoe of such m.etabo11tes.

Furthermore, there is no indication that CPZ 1s metabo-

lized in the brain, muscle, or lung.

Altogether, it is likely

that the 2-C1?N flguresr9ported here :tor blood, brain, musole or
lung, reter mostly to CPZ.

This ssems certainly true tor sbort

t1me intervals after the administration

or

CPZ.

Admittedly re-

sults reterring to liver may bear a different oonnotation, sinoe

a,. 87).

liver oonst.itut •• the .ajor sl'e of CPZ Jletabolis. ()9.

--

Tissue Dlstribution of CPZ

It is interesting that the.e data indio ate

ter ot intravenously
tissue..

ad~lni8tered

tran.-

CPZ trom the blood to other

\..,lthln ten minutes the blood levels ot CPZ were con-

a1stently low and did not refleot the levels of the
other tissues.

Qor~ound

in

It should be stressed that immediately after In-

jeotion very high levels of 2-CP1.i were

)

the lung.

~apid

However, this acoum.ulation

fOUl"ld

WB,g

in "the heart and in

only

subsequently heart and other muscle exhibited

and

tempor~y,
~elat1vely

low

levels of 2-CPN. wldle 2-CPB ooncentrations in the lung levelled

ott at a high plateau.
Data on the oonoentration. ot GPZ 1n the brain atter in
vivo administration vary extensively (39-43, 88-90).

This

va~1a

tlon may be due to the fact that, as in the oa.e of the present

•• thod, methods employed may not have been speoific for CPZ, even
though the data were expres.ed 1n terms ot the latter.

On the

16
()9), who used an ultraviolet speotrophotometrio method tor CPZ
determinatlon in dogs# and with those ot Christensen and Wase
(41), who employed S35 CPZ In mioe; both these groups reported
aocumulatlon and oonoentration ot CPZ In the braln.
On the other hand Fyodorov (40) who employed 53> OPZ
In rabbits, rat. and dogs; W.ohaler and Rolzin (42)wbo used an
ultrav101et speotrophotometrl0 method tor rats and. monkeys, and
Y.luda and Aoki (43) uslng rat. and a speotrophotometrl0 techni.
que, obtained low level. ot OPZ in the brain.

In tact, Wechsler

and Roizin (42) reported -'raoe." ot aPZ tollowing intramusoular
administration ot 100 mlorogm. per gm. ot this compound to rats.
Wechsler and her alsoolatea (42,48) suggested that the results ot
Salzman and Brodie ()9) oan be explained by inadequate reG overy
obtained by these investigatorsl this argument Gannot hold with
regard to our results, .1noe OPZ vas quantltatively reoovere.
trom the braln oy the pre.ent method.

Furthermore, deJaramillo

and Guth (88) tound reoover1 •• trom th. Weahller and Forrest
method were about

SO

per cent trom the braln.

Stlll another problem arls.1 with regard to distribution

ot CPZ within the brain.

Was. et &1. (89), using the radioisotope

method reported great d1fterenoe. between OPZ oonoentration. in
variou8 brain areaa, with the higheat levels found In the thalamua
.t.er single administration.

A JOO.told d1tter.noe was found

between oonoentrations 1n the thalamus and tbe oortex, and a 3told differen.e between those in the thalamus and the aereb.llu••
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Guth and deJal'8lIlillo (90) reported in a pre11m1nary study th.'
the levels of CPZ in the hy-pothalamus and in the lIled.ulla ot dogs
were 7-10 times higher than those in the oerebellum.

de Jaram1llo

and Guth (88) also reported negligible amounts of CPZ in the temporal and trontal oortex of dogs forty-five minutes following CPZ
injeotion intravenously.

However, Weohsler and Roisin (42) ad·f

ministered 1$0 miorogm. per gm. ot OPZ to monkeys and found l1tt14
ditterence in CPZ oonoentrations in the b •• al ganglia and in the
oortex, and on17 traces ot OPZ in the cerebellum and pons.

In

the pre.ent study, no suob pronoun.ed differenoe. were tound between CPZ oonoentrations in the brain stem, oerebrum, hippooam,l pus
and oerebellum, although the brain stem and the hippooampus
'

l

~.

retained 2-aPlf (or CPZ) so.ewhat bettal' than the other part. ot
the brain.
A partioularly interesting faoet

ot tbis study is that

tissue levels at CPZ or 2-CPN were measured over a forty-e1ght
hour period; thls 1s a longer t1 •• period than that covered by
earlier investigat1ons.
tor a long time.

In several t1 •• uem 2-0PN was retained

Atter .it aooumulated in the brain

4-$

told 1n

one hour, ita level deoreased slow111 even at torty-eight boura

it

di~

not fall sign1fioantly below that oorl'8spondlng to the

dose administered (40 rtUorogm. per gm.).

Retention ot 2-CPN 1n

tbe 11ver was even more pronounoed; moreover, the pattern of the
disappeara.noe ot 2-CPH trom the 11ver was difterent trom that
observed in the brain.

Atter a higb level ot 2-CPN was maintained
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in the liver for twelve hours after ita administration, it deWhile Fyodorov (40) and Salzman and

creased subsequently.

Brodie (39) also found high levels of CPZ in the liver, they reported that liver CPZ content deareased rapidly in rabbits, rats,
and dogs within tllr •• hours of its adUlinlstration.
The third tissue whioh aOQu.ulated and stored CPZ (or
2-CPN)

WaS

the lung.

aooumulating 2-CPN
longer period.

Tne lung differed fro. brain and liver by

110ft

extensiv.l,., and retaining It for a

Ind••d, in the lung. there was uo deol'ease in

2-CPN oonoentration troll ita peak at three hours tll1 forty-eight
hours atter ita administration.
Altogether, oontrary to the earliest Investlgatlons,

(39 .. 43) this studT indio"ted tha.t the 2-CPN oonoentrations do not
d•• rea •• uniforml,. in all tis.u...

Any tlssue,

th.r~fore,

might

exhibit the highe.t CPZ or 2-CPN oonoentration at anysp.aifio
ti•••

Ho explanation tor tbe •••hifts aan be given at pre.ent.
liDoe the liver 1a imp11cated iD the metabo11sm of CPZ by 1D
vi'PO Studi8. (4.7, 8S-81) it lIl8.7 be speculated that CPZ IIetabolia. may be induoed in the liver after a latent period.

Another

tattor may be the releas8 ot CPZ or 2-CPN trom variou. ti.sues.
and 1t• • torage in fat, where it. level is high in one and two
hours.

However, fat doe. not s.em as important

~;

.torage s1te

tor CPZ as for thiopental and pentooaroi.al ($0-$2, 91).
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Oorrelate.

!!

Pharmaoolof~o

Ao'lyltl and Brain

~

Level.

An attempt was made In . the cour.8 of this stuciy to
oorrelate the ohar.ges in oonoentI"'a.tions ot 2-0PN in brain wbltb.
occur with t1me with the intenslty or the pharmaoologic aotion
,ot CPZ.

It should be stressed, first of all, that the levels ot

CPZ In whole blood could not be used to prellliot the pharmacologic
.otlons of thls compound slnoe blood oonoentrations remained low'
and relatively oonstan'; trOll seven minutes to forty-eight hours
atter the administration of CPZ.

The temperatures ot OPZ-treated

oats rose above those of restrained oontrols after twenty-four

'0

thirty-two hours, while oerebI"'um oonoentrations ot 2-CPN deoreased to about 60 mlorogm. per gm., and thus was two or three tim.s
lower than the peak level.

At that t1.e the analges10 aotion or

CPZ, ascribed to the depre •• lon of the mldbrain retioular

fo~a

tion (92). was stl11 evldent, but the righting reflex had largel,.
reoovered.

Th. analge.ic etreat of CPZ, tranquilizat10n, and

anorexia perslsted even when the level ot 2-CPN in the oerebrua
decreaaed to 30 miorogm. per gm.
urements ot 2-CPN in

t~e

This,· too, suggests that .eaa-

braiD actually reter to OPZ itaelt, or

less 'probably, to an equipotent, unidentified, metabolite ot CPZ.
Thus, not All neuropharmaoologic a.otions of OPZ are terminated
simultaneously.

This could be explained if not all brain parts

lost OPZ--or 2-0PN--equally rap1dly; it

m~7

be suggeated th.'

tranqul11zatlon at rorty-eight hours depends upon relatively
high 1eve18 ot OPZ at that time in the braln ate. and the hippo-
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.ampUI, sinoe the latter Was associated with emotional behavior

(9).

!his sugge.tion i8 all the more speculative since the be-

havioral significanoe ot'various brain areaS is stl11 obsoure.
Interaotion

~ ~ ~~

Tissu! Homogenates

Interaction of CPZ with hornosenates of different tissues was observed

by

means of the equilibrium dialysis technique

utIlIzing a phosphate butfer system.

The preterential uptake

shown by the tissues in the Intaot animal was not evident by
equilibrium dialysis in the bufter sY8tem employed.

Homogenate.

of eaoh tissue, oerebrum, heart, li.er, and lung, prepared in
dilutions ot 1 gll'l. wet weight tissue per 100 ml exhibited respeotively similar uptake. at equilibrium ot about 400 microgm.
CPZ per ml ot homogenate.
CPZ or
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Approximately 225 miorogm. ot this

per ••nt vas bound to the ti.sue.
Bmpl,ying oerebrum

h~mogenate

as a representative ot

the.e tisaues, an inoreas8 ot the homogenate oonoentration to
1110 refleoted in a greater uptake

or

CPZ by the tissue to more

than 800 mlorogm. CPZ per ml ot homogenate at equilibrium.
this OPZ uptake, almoat 700 miorogm. or 87 per oent was

ot

bou~d

CPZ.

Whether 1:10 or 1:100 homogenate. were used during equili-

brium

dial~sls,

the bound CPZ tar exoeeded the oonoentration. ot

cpz round in the animal tissues in vivo.
It was observed from the oompeti tion ex;)eriments, that

is, those experiments in whioh single dialysis aS3embl!es con-
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thav eaoh of these tissues, cerebrum, heart, liver, and lung,
exhibited essentially sill11ar uptakes ot CPZ and thus, .each tissue displayed similar blnding ot OPZ.

These experiments provided

support that the d1tteren'llal uptake ot the tissues in v1vo was
not evident by the technique employed in vitro.
Since similar uptake and binding of CPZ by equilibrium
di&17S1s in the phosphate butfer system were exhibited by the
tour tissue., cerebrum was .eleoted as a representative tissue
to investigate some oharaoteristios ot tbiB system tor the
interaotion with tissue homogenates.

CPZ

Var,.ing ttl.e initial CPZ

concentration ot the outer ohkmber trom 0.1 to 1.0 roM resulted in
a linear increase of the uptake of the CPZ by the oerebrum homogenate. (1;100).

The 1 mM CPZ conoentration did not appear to be

at the limiting level tor the OPE uptake.

Neglig1ble eftectlJ b,.

telllPerature ohanges were obseMed on the equilibl-iUDl level of CPZ
uptake

b~

the cerebrum homogenates

exhibited. at

0-4 0

0 and 24-26

0

0

j

(l:lOO)--simil~

uptake. were

although tbe lower temperature

prolonged the period to attain equIlibrium, Goeurring at about
eight hours as compared to six hours. at room temperature.
ing the tissue homogenate at 90

0

Heat ...

C for two hoUl's or the ageing of

the homogenate also showed no sign1fioant va:t"iatlons of the up-

take or the amount of bound CPZ at equilibrium.
Tbe combination of CPZ wlth the tissue homogenate appeared f1rm.

Transter of the dialys1s bag to another assemb11

atter an uptake of OPZ in the first dialys1s .. sse_bly was
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e.tablished, or the performanoe ot the dialY8is experiment upon
oerebrum homogenates prepared trom an animal adainistere4 OPZ,
resulted in very little losa ot the bound OPZ (See results seotion 'l'able 12, oompare columns D and H; also 'l'able 13).

1'bu ••

oerebrum exhibited a rather stl'ong atfinity tor the bouad CPZ.
Kany factors may have c0ntr1buted to the difference

tbe result.

obtai~ed

in vitr-o as compared to the preferential

uptake ot CPZ exhibited by the tissue 1n vivo.
blood

tl~w

(94.95).

ot

Firstly, the

to the various organa investigated dltfers markedly
Blood flows through the heart and lungs and then the

blood is distr1buted 1n var10us peroentages to the organs.

In

Dorll8.1 human sub jeota at rest the blood flow has been e8 t11ua ted

(94) in pel' oent ot oardiao output as tollowB:
001"0119.1'1'.

lh BpIaooh1l10, 24, and. renal, 19.

cerebral, 13.

Estimates a.. ailable

tor the deg (95) Indloate that the blood flow to the heart, liver,
and kidneys ln peroentage of oard1ao output was 5.2, 10.0, and

11.1, respeatively.

Thus, ditferent amounts ot OPZ are delivered,

in unit tl .. , to each tiasue.

During equilibrium dialysis, the

extePDal medium ot the phosphate butter exposed the same amount

ot OPZ to each of the tissue homogenates.
Secondly, aome structural

oompon~nts

or the oellular

oompartmentalization which mil:,. be responsible tor the ditferential uptake and the binding of OPZ in the tiasuEt in vivo ma'1 have

been destroyed durlng Ule homocienizatioll procedure.

The preae1l0e

ot a blood brain barrier (96) or other membranes (91) haa been

8)
lnyolv.d in the mov.men1 ot drugs into and out ot an organ.
Preeman and Sprite. (98) have shown that human erytbroQytes can
co_bine w1th OPZ and they have attr1buted CPZ ette.1s to alteratlons ot membrane permeabllity.
a role, in vivo, preventing the

Perhaps these alterations play
ru~her

influx or outflow of CPZ;

the membranes are d1szoupted during the hOltlogenlzatlon prooedure
and tbus do not partioipate in nertlnent prooesses.

In the ab-

sen •• ot these alements various biochemioally identified, or as

".t unidentlfied, urll ts ot the 0.11 present 1n the homc.genate
aay then bind indisorimlnantly with OPZ.
Several oe1lular substances or components nave been

reported as capable of interaotion with OPZ, in vltro (96.10).
Barris, Saiter and Volk (100) reported CPZ bound slgnifioantly to
tbe .ganglioside strandln. a.nd also to ohrondroitln sulfurio aoid
and

hepa~ln.

Yagl at ale (101) reported

~

oomplex formation ba-

tween CPZ. at a Qono~ntrntlon of 10- 3 M, and the isoalloxazine
oompon.ant ot flavins.

Dingell at ale (102) reported tha.t OPZ was

boullc1 primarily to the partioulate matter of cells.

Mitoohondria

ls01ated fro. brain were found to exhibit greater aftlnit7 than
11 Vel' m11;oohondrla for OPZ (10.3).

The type

0:

CPZ with a cellular oonstltuent appeared to be
obtained from these
8tron~

experl~nts

affinity tor CPZ.

oOlnbinatlon ot
~irm.

The results

indicated that the tisau.s had a

In the absence ot the struotural

OOM-

ponent!! and differential blood flow present in vivo the cellular

oo.ponenta ma7 be capable of interact1ng ill vitro to a difterent
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extent than

tha~

.e.n in vivo.

Bhrenprela (99) had reported that OPZ exhibited binding
capabilltie. to the protein he Is01ated by fractionation with
a_onlum sulfate and whioh at first (61) was oonsidered .a a
"receptor" for acetyloholine but later (104) as the "drug binding
oomponent ot oonducting membrane only".

Hiatochell1oal resul'.

obtaiaed hy Ehrenpreis (104) indioated that the !lreoeptor" protein was present in oloae proximity to, or a part ot, the
brane.

"111~

He suggests the possibility tbat this protein may be of

.embranous origin.

Spirtes

an~

ooworkers (98, 105-107) have also

implied tbat CPZ ett•• ts were related to alterations ot membraD.
perlleability.

The looation of CPZ aotivity on the BlEuerane may

be related to the faot that .ell membrane. are Gompoaed primarily
of lipid, that ls, phospholtpid.
Some physical and ohemical Gharaoteristi •• described b7
BbPenprei, (104) for the drug-binding protein were that it did
not gel on heating and that it contained a significant amount of
phospholipid.

In the equilibrium dialysis experiments reported

at pre.ent, brain hOMOgenate. h.ated in phosphate

but~er

7.1 s1'1owed no apparent alterat;ians of the binding ot CPZ.
hap.s

at pH
Per-

the oellular struoture described by Ehrenpreis may be impll-

oated 1n the binding of CPZ in the pre.ent experl ••nts.
So.e conalderatlon may also be gIven that OPZ, a lipophilic compound, may have become bound to the lipoprotein, or to
the sphlngo11plda, tor example, the oerebroside. or gangliosid•••

and aangllo.ide. ooour in tl •• ue. otber tban in

Oere~ro.id.8

Drain.

The gangliosidel have been found in mo.t parenohymatou.

ti.luea, tor example, .pleen and erythrooyte..

However, the ti.-

lue. fnye.tigated ezh1b1t ditterent ganglio.14e Gonoentration.;
OR

the baaia ot phosphorus per 100

sm.

freah ti •• ue, rat liy.r

oontain_d on.-halt the ...ount of sphingomyelin round In rat heart
and about one-thlrthieth that ot cat hrain (108).

Theretore, 1t

1. unlikely that the bindilll .rteat. in vitro _., be attrihuted

aolel,. to the bind1ng to ganglioside ••
-An explanation ottered by Harri. et &1. (100) tor the
signitloant

bindi~g

of CPZ to

st~andin#

a rather apeoiti. gangli-

.aide trom the brain, was that the reaction ooourred between the
oerbolt,.l group of the neuramin10 Acid in the ganglio.ide and tb.e
overall pos1t1ve oharge of CPZ.

The v1ew that N-aoetyl neura-

mlnl0 aold ma7 be involved in the role of the ganglio.idle bind1ng of CPZ i . po.aibly supported by the work reporteel by Irwin
et al. (109).

'lhe.e inYeatigator. found that ganglioside. pre-

vented the bloeklng activity of CPZ on aoetyloholine stimulated

trog reotu. mUlol..

Partial destruotion of 1Ihe ganglios1de ao-

tlvit7 against tbe OPZ aotion o •• urred when .·ao.tylneuraainio
ao14 waa removed by aoid hydrolysis trom tbe ganglioaiele.
When the role ot auoopoll.aoohar1de.t tor ex. .pl ••
'byaluroni. aolel, b.epariD, and the ohondroltlQ sultate., wbioh
oonstltute intesra1 components ot the muooproteins, 1. eluoielated.
perbaps tbe Ind180riminate bindlng exhibited by tbe ti.sue. in
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vitro .ay be olarified.

Ohondroitin sulfate has been found pre.

sent in the heart valves, the skin, the cartiage, tendons and
bones.
The

Heparin is also present in various aniJU.l tissuea (110).

homogenizati~n

procedure may release these sUDstanoes trom

oertain toroes existing 1n vivo whioh exert a ditterentiating
ettect tor tbe oombination of CPZ with thqt particular organ.
'lb. results obtained with blood in vitro could pos8ibl,.
b. extrapolated with the results obtained in vivo.

Uptake and

binding ot CPZ by blood, when whole blood (lrlO) oonstituted the
inner oompartment during eq u:11ibrlultl dia1ys1a, was lIuoh leas than
tbat exhibited by comparative amounts of the other tissues.

Thus,

the low uptake of CPZ by blood in vibro may b. considered as
favorably oomparing witb that found In vivo.
However, when undiluted blood oontalning CPZ oonatltnted the outer compartment whioh
ate • •s the inner

ohamber~

WIiS

used against tissue hOMogen-

very little OPZ penetrated the d1a1181.

bas-·that 1s, not even the equilibr1um ooncentration in the
oompartments was atta1n&d.

1nne~

Thi. is unlike the findings in vivo,

In whioh tbe tissues displayed a rapid uptake of CPZ trom the
blood.

CPZ may bave be.n, bowever, preoipitated by the blood and

th1s would prevent dialys1s of CPZ from the outer to Inner ohambel'.

OPZ, at 10-3 H, was preoipitated 1n phosphate butter at pH

7.4--tbe approxImate normal pH of blood.

The white crystalline

preoipitation ot CPZ was not observed in the blood, in vitro.
At tbe termination of the experiment the blood had a pH of 7.2--
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a pH at which CPZ i. soluble.

8.2 (111).

Thus, even at pH

Fupthermore, OPZ has a pKa ot

1.4

enough CPZ should have. b.en

ionlzed to ettect an inward migration to the binding slte. ot tbe
ti.su.a.
It 1s conceivable tben that the whole blood, in vltro,
oould b1nd the CPZ, 1t CPZ were presented to 1t tirst, and if tb.
t&otors pre.ent 1n vl"o, whioh induce the release or OPZ tro. the
blood to tbe tis.ue., were not actl"e in v1tro.

In v1vo, blood

was capable of Inlt1ally ooncentratlng approximatelT 300 microgm.
CPZ per III (Ie. Pig. 10, Results), e"en though tor a short dura-

tion.
Also, it sbould. be remembered that 1n v1tro, undiluted
whole blood oontaining CPZ was dialyzed aga1nat ti.su •• at lslOO
dllutlon.

This tia.ue conoentratlon ditterenoe maT in Itselt

aooount for tbe failure of the blood to rel.as. CPZ 1n vitro and
may be a faotor which could be reoonoiled by oomparing blood conoentration versus tis.ue ooncetration in v1vo.
The blood u.ed in th•• e experIments contained heparin
whioh had been added to prevent Ita coagulation.

Tbe binding ot

OPZ by heparin haa been reporied by Harri8 e' a1. (100).

Perhaps

the pre.enoe ot heparin Ilay explain 80•• ot the etteot. toward
the uptake and blnding ot CPZ by the blood ln vltro.

How.ver, a

oonolusive interpretation of the heparin ette.t on the blood-CPZ
lnteraotloR 1s preoluded by the influenoe whioh may be exerted by
the tollowing obse'rva.tions: ,;
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Firstly, the gradual los. of antiooagulant and

an~l

oomplementary aotivitie. of heparin inaubated with a washed red
blood oell auspenaion was considered as indioativ. ot a disappearanoe and possible absorption of heparin (112).

Thus, the binding

of CPZ observed in the.e experiments with the blood may not have
b •• n influenoed by the presenoe ot heparin.
Seoondly, heparin 1s normally found in varying

~onoen

trations in the liver, lung, spleen, musole, heart, and other
tissue, expeoially the mast oells (110).

The destruotion of the

.ast ••11 by CPZ reported by LeBlano (113) aay oause the release

ot a rioh supply ot heparin.

But, homogenate. ot liver- and lung,

both known to 00nta1n large amounts ot hepar1n (110), exbibited
sim11ar uptake and per oent bound CPZ as that obtained by the
other tissues t"bIob <lontain lesser amounts of heparin.

This con-

siderat10n tends to minimize the influenoe that the endogenously
preduoed heparin mal bave had toward the etfect ot tbe bIndIng ot
OPZ by the blood or the tissue.

Thirdly. al'bough under nO!'l11al oondit10n., heparin i .
not in the free state in the body, 1t is known that tree heparin
lIay appear In 80.e abnormal oondi tiona.

Dogs in anaphyla.otl0

shook oan relea •• heparin troll the liver (110).

The withdrawal

of tbe lapge volume (about 110 ml) ot blood troa the
animal. produoed ••vereshook.

Oonoeivably, heparin

~at,

11U",.

a

sm~ll

have

been relea.ed trom the liver ot the oat so .s to attain a signifioantly high tl ter in the blood.

Tl.e le"el.

ot tbe endogenously
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proc!uoed heparin plua that added to prevent the coagulation ot
tbe blood -1 bave been signiticantly high

OPZ bJ tbe blood may be

at~ributed

80

that the binding ot

to the presenoe 01' heparin in

these experimenta.
Further Intere.t in binding etteots 01' CPZ with heparin
oould posaibly oenter on the gluouronl0 aoid or other aold moletiea present in beparin.

Slnoe in theae experimenta, bornogenatea,

and not purif1ed blooheminally Ind.nt1t1ed oonstltuenta were employed,

perh~pa

an explanation tor the lndisoriDd.nate In vitro

blnding ob.erved here may be due to the aotion of carboxyl groups

ot various compounds auoh as the B-aoetylneuramio aOid, and the
glueuronio acids of hepa.rin , hyaluron10 a.o.1d and the ohondroi tin
sulfate. whioh may oombiQ$ with the overall po.itive oharge ot
OPZJ the.e groups may be indiscriminately distributed in all tis-

sue. studied.
Another cODsideration pertaining to tha in v1tro study
ot blood is that CPZ oan, in vltro, combine with the red blood
.ell. and alter the oamotio permeability of the erythrooytl0
brane (98).

me~

Perhapa, onoe the red blood .ella have taken up CPZ,

the al tered osmotio parmaabilit,. prevented the relea.se of OPZ to
the tissue hOMogenate8.

'l'n. explanation

ot t;he binding of

OPZ by

the erythrooytes in :vitro .erit further investigation.
Thua, many questions are presented troll the results obtained, in vltro.

It is iYlteresting to attempt to identity tbe

oomponent or components that exist in vitro and in vivo whioh
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bind CPZ.

Extension ot results obtained trom equilibrium dialy-

sis upon purified proteins isolated from the tissue could provide information to oaloulate the energy ot association ot each
ion

a~

well as the number ot sitee available tor the binding ot

the ion.
8ub8t~~C.8

Approaches through the Gombination ot CPZ with purified
hay. been reported (100).

The attempt to isolate the

OPZ-..reoeptor by fraotionation of the C'PZ bound tilsue presents
Many difficulties, perhaps the most important Is that through
means of ohemical differentiation the CPZ may separate

tteoeptor oomponent.

tl'OIl

its

Some prellmina.ry experiments have been at-

tempted in this dipeotlan.

OHAPTER VI
SUMMARY

1.

A speotrophotometrl0 prooedure tor tbe quantltatlve

analy.l. ot CPZ trOB biologl0 ti •• ue. baaed upon the extractioD
or CPZ lnto alkaline ether and sub.equent oxidation by terrl0 10n

1. the pre.enoe ot oODGentrated .ulfuriG aold 1. de.orlbed.

Re-

Goverle. ot OPZ tro. brain by .ean. ot thl. method amount_d. in
v1tro, to 86.6 i 6.6 per .eat.
2.

The pro.edure was apeoltlo tor apz and other 2-

oblorophenothiaz1ne. posseaalDI a side ohain OD the riD8 nltrosen
Ohan,e. ia the phenothiazine nuoleus or sub.titution. tor ohloplne in posltlon 2 pesulted 1n oolors whiob differed fro. the
oherry-red ohromophol"e.
e.'abli.hed.

Speotl"a tor un,- of thes_ oompouad. were

Thus, beslde. CPZ, other related oompound. oan be

8.Qu.,sed ln ti.aues 1ry mean. at th.l. .."hod....

J. Tlssue levels of CPZ tollowinS lts intravenoua
1nJeot10n lnto oat. were determined by this •• thod.
following the adaini.tratioD ot CPI,

Immediate1.,

40 microgm. per gm., level.

near 1 ag. per gmt Gould be determined in tbe heart and in the
luns.

There was a rap1d sh1tt ot OPZ tro. the blood to other

tlslue ••

4.

CPZ oonoentrated

to~r

or five told ln the lung,

l1ver, and brain at one hour atter It. adminIstration, at whioh
91
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ti.. the content ot the heart and other tissues was relativel,

low.

GPZ content re.lned high in the 11 Vel" and in the. lung

tor tw.lve and forty-elght hours respeotively.

S.

Pharmaoological aot10ns ot ohlorpromazine d1d not

terminate simultaneously.

H1Po'her~a

and analgesla seemed as-

soclated with the )O-sO microgm. per 8m. CPZ levels in various
parts ot the bl"ainJ tranqulllzat10n appeared to l"eQ.uire lesa
CPZ.

6.
CPZ

utilIzing equilibriuDl dialysia, the 1nteraotlon ot

with the various tissue homogenate. ooourred in a phosphate

butter s7atea·..

!he preferential uptake tor OPZ exhibited by the

tissu •• in vivo was not eV1dent in vitro, and dialysia ot the

tour tlssue. 1n single aas8m'118. did not show oompetitlon tor
CPZ uptake.

7. Cerebrum homogenates
tor the CPZ.

eXhiblted a stroug attinitr

.egligible amounts of the bound CPZ wer8 released

tram the tissue. when cerebrum homogenate. oonta1nlng CPZ were
dialy••• against phosphate butter.

6.

A dl.oullion of the various struotural oomponents
,

to whlch OPZ may bind was presented.
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APPENDIX I

'reparation of Phosphate Buffer Solutions lJa'.ld. tor the
Bquilibrium Dialysis Experiments

stock solutions of tbe sodium monohydrogen phosphate!
(Wa2BPOh) and potasslum d1bydrogen pbosphate (KB~P04J
pr~~~rea as de.crlbed In tbe t3Y.t were mixsd In ~.
proportlc~s indloated below.
Th pH ot the resulting
801ut10n was checked on the Beckman Zeroaatic pH meter.

lafHP 04

KH2P04

pH

9.00

1.00

8.00

2.00

7.00

).00

7.648
7.347
7.146

6.00

4.00

6.976

5.00

5.00

6.813

111)

I

(Ill)

!his table 1s III port1on of tbat found 1n Gortner, R.A.
and Gortner, W.A.. Out11ne. ot Bioobemistry, )rd Ed.,
John Wiley & 30ftS, Inc., New York, 1949.
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APPENDIX II

!he dirtepenc •• , top all time periods investigated, b.lw.en the

oerebrum and the oerebellum, and between various bra1n stem are.s
and the hippooampus on on& hand, and the oerebellum on tbe other,

were round signifioant at p

> 0.05 level.
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